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Abstract 
 
Since the first compartmentalized neuronal culture described by Robert B. 
Campenot in 1977, compartmentalized microfluidic devices have been widely used to 
engineer the cellular environment for cell culture. In previous research by Dr. Anja 
Kunze, a microfluidic device was able to build a “co-pathological” model with neuronal 
culture for neurodegenerative disease studies. In this model, two neuronal populations 
were cultured in independent compartments, while the axons of both populations were 
able to grow away from their own population and arrived in the same compartment, 
which was between the two compartments for the neuronal populations. When one neu-
ronal population was exposed to a drug and expressed a specific disease state, different 
disease states were observed in the axon compartment towards the other unexposed cell 
population. This co-pathological pattern was achieved and early stage of disease propa-
gation was observed in this compartmentalized microfluidic device. An example of this 
propagation pattern in the native brain is the well-known neurodegenerative disease 
Alzheimer’s disease (AD), which still lacks effective treatments. In the AD brain, disease 
progression is observed from one brain region to another, eventually influencing the 
whole brain. This disease model can be mimicked in vitro within microdevices to assist 
neuroscientists in gaining a better understanding of the mechanisms of AD spreading in 
the native brain. 
In this thesis, we designed and fabricated compartmentalized microfluidic devices 
to build a co-pathological model to study the propagation of Tau pathology, which is one 
of the key pathological hallmarks of neurodegenerative disorders. Besides the morpho-
logical characteristics that we observe using our microfluidic device, microelectrode ar-
rays (MEAs) technology, which is based on microtechnology and allows for recording 
extracellular neuronal activity, was integrated with the microfluidic device in this work. 
Together, the microfluidic and the integrated microfluidic-MEA devices provide us the 
possibility to monitor respectively time-variant morphological and electrophysiological 
alterations during disease spreading. We are therefore able to distinguish the contribu-
tion of neuron-to-neuron transmissions, observe different patterns of disease propaga-
tion with high and low drug-induced AD models, and observe the order in which the 
structural and functional alterations occur during AD progression. Based on the results 
that were achieved during our investigation of AD in this thesis, these microfluidic and 
integrated microdevices may potentially be used to study neurodegenerative diseases 
and perform pharmaceutical drug tests. 
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Résumé 
 
Depuis que la première culture cellulaire de neurones compartimenté fût décrite 
par Robert B. Campenot en 1977, les dispositifs microfluidiques compartimentés ont 
beaucoup été utilisés pour le contrôle de l'environnement cellulaire dans la culture de 
cellule. Dans les travaux de Dr. Anja Kunze, un dispositif microfluidique permettait de 
construire un modèle "co-pathologique" de culture de cellules neuronales pour l'étude de 
maladie neurodégénératives. Dans ce modèle, deux populations de neurones sont mises 
en culture dans des compartiments indépendants. Les axons peuvent grandir vers un 
compartiment commun qui se trouve entre les deux compartiments contenant les deux 
populations de neurones. Quand une population de neurones est exposée à une drogue et 
exprimait un état spécifique d'une maladie, différents états de cette maladie ont pu être 
observés dans le compartiment des axons, vers la population non-exposée de neurones. 
Ce schéma co-pathologique a été réalisé et les premières étapes de la propagation de la 
maladie ont été observées dans ce dispositif microfluidique compartimenté. Un exemple 
très connu de cette forme de propagation dans le cerveau est la maladie d'Alzheimer, qui 
n'a pas de méthode de traitement efficace pour l'instant. Dans le cerveau affecté par la 
maladie d'Alzheimer, la propagation de la maladie est observée d’une région du cerveau 
vers une autre, pour finalement influencer tout le cerveau. Ce modèle de la maladie peut 
être imité in vitro dans des micro-dispositifs pour aider les neuroscientifiques à mieux 
comprendre les mécanismes de la propagation de la maladie d’Alzheimer dans le cer-
veau. 
Dans cette thèse, nous avons conçu et fabriqué des dispositifs microfluidiques 
compartimentés pour générer un modèle co-pathologique pour l'étude de la propagation 
de pathologie Tau, qui est une des principales caractéristiques des troubles neurodégé-
nératifs. Mise à part les caractéristiques morphologiques que nous observons dans notre 
dispositif microfluidique, la technologie des matrices de microélectrodes (MEAs), qui est 
basée sur la microtechnique et permet de mesurer et d'enregistrer l'activité neuronale 
extracellulaire, a été intégrée avec le dispositif microfluidique durant cette thèse. En-
semble, les dispositifs microfluidiques et microfluidique-MEAs nous permettent d'obser-
ver en fonction du temps respectivement les altérations morphologiques et les altéra-
tions électrophysiologiques pendant la propagation de la maladie. Nous sommes alors 
capable de distinguer la contribution des transmissions neurone à neurone, d'observer 
les différentes formes de propagation de la maladie pour des modèles d'Alzheimer avec 
haute et basse induction par des drogues ainsi que d’observer dans quel ordre les altéra-
tions structurelles et fonctionnelles se produisent pendant la propagation de la maladie 
d'Alzheimer. Basé sur ces résultats qui découlent de notre investigation de la maladie 
d'Alzheimer dans cette thèse, ces micro-dispositifs microfluidiques et intégrés pour-
raient potentiellement être utilisés pour étudier les maladies neurodégénératives et pour 
effectuer des tests pharmaceutiques de médicaments. 
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Alzheimer’s disease (AD) is a well-known neurodegenerative disease of the brain. 
One of the main characteristics of AD is its aggressive propagation between the involved 
regions, but the mechanisms of disease propagation remain obscure.  In order to under-
stand AD progression in vitro, innovative tools that can allow interaction-controlled neu-
ronal cultures and can distinguish complex functions in the neuronal network are re-
quired. Microfluidic technology, which is developed for precise manipulation of fluids 
through compartmentalized microchannels, has been widely applied in cell morphologi-
cal studies, including neuroscience research. Microelectrode arrays (MEAs) technology, 
which allows for action potential recordings in excitable cells through the use of multiple 
microelectrodes, has been applied in neuronal electrophysiological studies as well. In 
this thesis, we integrate these two microtechnologies of combined microfluidic and MEA 
platforms to investigate AD disease propagation in vitro in a more comprehensive man-
ner. Through the use of a compartmentalized channels structure within our microfluidic 
device, we build diseased and healthy “co-pathological” neuronal networks to mimic AD 
disease propagation and attempt to observe the alterations of morphological and elec-
trophysiological characteristics during disease progression. We are moving towards 
building a “brain-on-a-chip” using microfluidic and MEA platforms, which may potential-
ly make significant contributions to disease studies and pharmaceutical tests. 
 
1.1 Alzheimer’s disease  
1.1.1 AD and its hallmarks 
Alzheimer’s disease (AD) is one of the most healthcare cost-intensive neurodegen-
erative diseases in the world with no efficient cure existing at present. The disease 
mechanism is still uncertain after many years of debate. The first symptoms for Alz-
heimer’s disease (AD) were described at a conference in Germany by Dr. Alois Alzheimer 
in 1906. Later, in 1910, these symptoms were named “Alzheimer’s disease” by Emil 
Kraepelin [111]. AD is a progressive neurodegenerative disease in the brain. Often, AD 
lesions propagate through the patient's brains for years before any symptoms appear. As 
the disease develops, impaired judgment, disorientation, confusion, abnormal behavior 
and difficulties in speaking, swallowing and walking start to appear, and gradually, AD 
gives patients more troubles in daily life, with cognitive and functional abilities declining 
and finally leading to death [3]. Under the situation that the disease mechanism is un-
clear, the diagnosis for the AD patients is uncertain and requires a series of medical as-
sessments. After inquiring into a patient's symptoms in detail, physicians also need to 
analyze the patients’ family's medical history, undertake cognitive tests, physical and 
neurological exams and biomarker tests (e.g., blood test, magnetic resonance imaging). 
However, more scientifically relevant diagnostic criteria are required for the clinical di-
agnosis of AD, such as biomarkers focusing on essential AD hallmarks. 
AD, like the other neurodegenerative diseases, displays a spreading pattern through 
1. Introduction 
3 
anatomical connection across memory-related brain regions. It starts from the entorhinal 
cortex and progresses to all the hippocampal related sub-regions (including dentate gy-
rus, CA3, CA1 and subiculum) and finally spreads to the cortical areas via anatomical 
connections (Figure 1) [97, 57, 17]. During AD propagation, two major pathologies play 
an important role in the brain: the deposition of extracellular amyloid-beta (Aβ) plaques, 
and intracellular hyperphosphorylated Tau (hp-Tau) neurofibrillary tangles (NFTs) 
(Figure 2) [9, 124]. Aβ plaques are composed of peptides cleaved by β-secretase and γ-
secretase from the amyloid precursor protein (APP) (Figure 3) which is an integral 
membrane protein probably in charge of synapse formation [130], neural plasticity [151] 
and iron export [35]. NFTs are composed of aggregated and fibrillary hyper-
phosphorylated (hp) microtubule-associated protein (MAP) Tau protein (MAPT) (Figure 
4). More recent hypotheses have explored the role of Tau oligomers and their toxic ef-
fects [155], and have focused on the correlation between Aβ and Tau protein [68]. Based 
on the theories of Aβ and NFTs, neuroscientists are focusing on promising therapeutic 
approaches such as anti-amyloid or tau based drug development to reduce amyloid-beta 
production, prevent amyloid-beta aggregation, and promote amyloid-beta clearance 
[101]. As the common histopathological hallmark of AD, the “Aβ cascade hypothesis” was 
first proposed to explain the pathological mechanism of Aβ neurotoxicity, which strongly 
contributed to the development of AD therapy [61, 56, 55]. The current therapeutic ap-
proaches in clinical trials are mainly focused on reducing of Aβ level, but unfortunately, 
remain unsuccessful after several treatment candidates [50, 51, 33]. Hp-Tau, another po-
tential therapeutic target is attracting the attention from researchers as well because of 
its strong correlation to cognitive decline in AD compared to Aβ [97, 17]. The hallmarks 
of AD provide clues (e.g., determining the level of Aβ accumulation in the brain) that 
should be investigated in order to better diagnose AD early and accurately [147].  
 
 
 
Figure 1: Medical information of brain scans from an AD patient from 1993 to 2003 by Magnetic resonance 
imaging (MRI). This evidences showed how the disease progresses: Hippocampus (red) and entorhinal 
cortex (yellow) shows an apparent shrink, meanwhile the ventricular system which contains cerebrospinal 
fluid (green) increased in volume during the 10 years of disease propagation. Reprinted from [9] with 
permission  
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                                                  A                                                                                                B 
Figure 2: Plaques and tangles in the cerebral cortex in AD.  (A) Schematic pictures of healthy neurons 
(left) and diseased neurons in AD brain (right) (B) Stained tissue from a diseased brain. Aβ plaques are 
the round structures. The triangular shapes are the neurofibrillary tangles made of hp-Tau. Reprinted 
from [4] with permission from Elsevier 
 
Figure 3: Comparison between healthy neuron and Alzheimer diseased neuron.  Image courtesy of the 
National Institute on Aging/National Institutes of Health. 
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1.1.2 Formation of NFTs from Tau protein  
In this thesis, we focus on the Tau pathology of AD. Inside a healthy neuron, MAPs 
are the proteins that can interact with the microtubules of the cellular cytoskeleton to 
regulate the stability of the microtubules. Tau protein is one type of MAPs also called mi-
crotubule-associated protein Tau (MAPT). It can interact with tubulin to stabilize the mi-
crotubules and promote the tubulin assembly into microtubules [90].  Tau protein is a 
highly soluble MAP, not present in the dendrite and is primarily in the distal portions of 
the axon [8, 79] where it stabilizes the microtubules [15]. It is a vital factor in regulating 
microtubule dynamics, axonal transport and neurite outgrowth, and all these functions of 
Tau are modulated by site-specific phosphorylation [72]. Tau protein dephosphorylation 
helps to prevent dimerization and subsequent PHF formation [7]. When Tau protein is 
regulated in an abnormal way, it becomes highly phosphorylated Tau (hyperphosphory-
lated-Tau, hp-Tau). Afterwards, the aggregation of hp-Tau becomes the major component 
of the paired helical filaments (PHFs) [7] and together with straight filaments [53] forms 
NFTs, one of the hallmarks of AD and other Tauopathies [26]. During this spreading of 
AD, the neuron-to-neuron transmission has been proposed to be important [109]. More 
specifically, the spreading of Tau pathology was observed along the synaptically connect-
ed circuits in a transgenic mouse model and this indicates that the secretion of Tau by 
 
Figure 4: Comparison between healthy neuron and Alzheimer diseased neuron on Tau protein.  Image 
courtesy of the National Institute on Aging/National Institutes of Health 
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presynaptic neurons and its uptake by the postsynaptic neurons could be the sequential 
events leading to the propagation of Tau pathology in the brain [109].  
We investigate this neuron-to-neuron transmission theory during AD progression 
in an AD model in vitro using compartmentalized microfluidic device. In order to further 
study the function of the axonal network during disease propagation, we distinguish the 
axonal network from the other parts from the neuronal network to exclude other factors, 
e.g., the dendrite-axon interaction and the the soma-axon interaction, only focus on the 
axon-axon transmission of Tauopathy during the disease propagation.    
1.1.3 Propagation of Tau pathology in AD 
Degeneration in AD starts from the transentorhinal cortex (A), spreads to the hip-
pocampal formation, anterior temporal cortex and polymodal and unimodal association 
areas, (Figure 5 B) and eventually invades the entire cerebral cortex in the final disease 
state (Figure 5 C) [36]. Neurofibrillary tangles (NFTs) as a hallmark of AD, have been 
tracked to observe disease propagation in vivo by following the microtubule-associated 
Tau protein (MAPT) in a transgenic mouse model, and it has been observed that Tau pa-
thology has evolved in the same predictable pattern as the early neuropathological de-
velopment of AD [17]. More specifically, the spreading of Tau pathology was observed 
along synaptically connected circuits, and this result indicates that secretion of Tau by 
presynaptic neurons and its uptake by postsynaptic neurons could be the sequential 
events leading to the propagation of tau pathology in the brain [109]. All these data sup-
port the hypothesis that the local Tau aggregation can be transmitted from neuron to 
neuron, which plays an important role in the progression of Tau pathology. 
To date, there is no cure for AD and no pharmaceutical company has succeeded in 
developing a fully effective treatment against the progression of AD symptoms. This 
pressing situation encourages us to develop novel experimental approaches to better 
understand AD. It is imperative to acquire proper models and tools, which allow for 
more accurate control and multifunctional tests both on disease mechanism and diagno-
sis studies, based on the mechanisms of Aβ plaques or NFTs have already been identified. 
 
 
                             A                                                                     B                                                                C 
Figure 5: AD spreading through the brain.  Image courtesy of the National Institute on Aging/National 
Institutes of Health 
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1.2     Morphological studies  
1.2.1 In vivo and in vitro models to study AD 
In order to understand AD mechanisms comprehensively, both in vivo and in vitro 
models have been developed [99]. In vivo studies take advantage of the full complexity of 
the brain structure and function; however, the functional and molecular pathways still 
cannot be clearly understood. To understand structural connections and their impact on 
the diverse range of brain functions during neurodegeneration processes, in vitro models 
that allow for controlled interaction are indispensable. They open the possibility of bet-
ter understanding the mechanisms of the propagation of AD in a more controllable envi-
ronment, where we are able to study cellular and molecular mechanisms in a simplified 
and controlled way. Nowadays, studies on AD are usually performed in conventional cell 
culture tools such as plastic petri dishes or multi-well plates for a large number of exper-
iments. In order to understand AD progression in vitro, novel tools that help to distin-
guish the different functions of each component in the neuronal network and their con-
tribution during disease progression are required. 
1.2.2 Microfluidic technology for in vitro neuroscience research 
Micro-electro-mechanical systems (MEMS) is a technology which combines minia-
turized mechanical and electrical components developed from microfabrication. Lab-on-
a-chip (LOC) is a subset of MEMS that provides high sensitivity and resolution in experi-
ment by manipulating small amounts of sample in a single chip. Microfluidics, which is 
related to LOC, is developed for precise manipulation of fluids at the submillimeter scale 
and was first applied in cell biology in the 1980s [104]. Nowadays, microfluidic devices 
have been widely used in biological and biomedical applications, and have involved in 
neurological studies as well. The first in vitro compartmentalized neuronal culture was 
described by Robert B. Campenot in 1977 (Figure 6) [119]. In this three-chamber neuron 
culture system, neurites from the sympathetic neuron somata grow through the en-
graved glass to other chambers built by fluid impermeable barriers, so that the neuron 
soma and their neurites still keep their physical connection, but are cultured in different 
environments [18]. Campenot’s isolated chamber model gave the possibility of culturing 
neurites and somata separately in compartmentalized environments in the scale of mil-
limeters to micrometers. This was when the compartmentalized neuronal culture con-
cept started and has since been better implemented in microfluidic devices because of 
the rapidly advances in microtechnology.  
1.2.3 Characteristics and fabrication techniques for a microfluidic de-
vice  
Our microfluidic devices are produced in a cleanroom from the Centre of Micro and 
Nano technology of Swiss Federal Institute of Technology (Lausanne, Switzerland). In 
this cleanroom, the working environment provides controlled level of contamination, 
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specified by the number of particles per cubic meter. This can largely avoid the environ-
mental particles on our device such as dust and chemical vapors. This is crucial for mi-
crofabrication because the functional elements from the products are at the microscale, 
which makes it sensitive to pollutants. Our microfluidic device for neuronal culture re-
quires several microfabrication techniques including Photolithography, Wet oxidation, Si 
DRIE etching, Si and SiO2 RIE etching and device molding. Benefitting from the use of 
these techniques, we have the ability to fabricate chambers of different heights in a single 
device. By adequately choosing the heights of different chambers in a microfluidic device, 
we can isolate the neuron body (around 20 μm in diameter) in one compartment and 
only allow the neurite (which may be either a dendrite or an axon) to grow through a 
narrow channel, which we call the junction channel. The theory of using junction chan-
nels for neuronal culture is shown in Figure 7. Depending on the length of the junction 
channel, we can also isolate the dendrite and axon, which have very different lengths. In 
the case of a long junction channel, the dendrite is not long enough to grow out of the 
channel and only the axon can grow out of the junction channel and reach another isolat-
ed compartment (Figure 8) [144]. By using junction channels, we can obtain and observe 
an isolated axonal network without interaction from the cell soma and dendrite, and this 
is one of the main advantages of using microfluidic devices for neural culture. In brief, for 
our morphological study on AD propagation, the microfluidic device allows us to mimic 
disease propagation patterns with an isolated axonal network. The culture medium and 
drug exposure are precisely and locally controlled at the microscale. 
 
 
 
Figure 6: The first compartmentalized microfluidic device for neuronal culture.  The three chambers 
were divided by a Teflon set-up which is sealed to the petri dish with silicone grease. The neurons were 
plated in chamber a and the neurites grew into lateral chambers b and c by the guiding of a series of 
scratches in parallel [15]. 
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Figure 7: Schematic diagram of the manipulation with microfluidics for neural culture.  The channel that 
blocks the cell soma and let the axon to pass through is called the junction channel. The height of the 
junction channel is smaller than the diameter of the neuron, so that we can use the junction channels to 
isolate the axon from the neural soma and build an isolated axonal network in a different environment 
 
Figure 8: Variation of the junction channels (150 μm, 450 μm, 900 μm) for the microfluidic device to 
isolate neurite or axon.  When the junction channels is 450 μm or more (14 DIV), the dendrite cannot 
grow through the junction channel (green, MAP2), and the axon (red, Tau) was observed growing 
through to the end of the junction channels (dashed lines indicate the end of the junction channels). 
Reprinted from [16] by permission from Macmillan Publishers 
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1.2.4 Microfluidic device and its application on neuronal culture  
Microfluidics, a multidisciplinary field involving manipulation of liquids and gases 
in micro-scale channels, has become one of the central technologies in miniaturized sys-
tems and has been applied in many disciplines such as physics, chemistry and biology. 
The miniaturization using microfluidics produces a lot of advantages, for instance, small 
quantities of samples and reagents, carrying out separations and detections with high 
resolution and sensitivity, low cost, short time for analysis and portability. Historically, 
silicon has been the most widely used as the base substrate material for fabricating mi-
crofluidic devices [93] benefitting from its suitable electrical and mechanical properties 
for microfabrication. However, Si is relatively expensive for mass production of disposa-
ble devices and its opaque property makes it less compatible for microscopy analysis 
[107]. Many new types of material have been used for microfabrication, especially poly-
mers such as polycarbonate (PC), polymethylmethacrylate (PMMA), polyvinylchloride 
(PVC) and polyethylene (PE) [105]. One of the most used polymers is polydimethylsilox-
ane (PDMS). PDMS is a silicone elastomer with desirable properties such as transparen-
cy, gas permeability, biocompatibility and low cost, which make it attractive for micro-
fabrication. All these aspects make PDMS an excellent material for the fabrication of mi-
crofluidic devices for biological use. PDMS is viscoelastic and the solidification of PDMS 
can be accelerated by adding a curing agent. That is the reason that we usually use a 
PDMS base together with a curing agent to make PDMS mixture. When the temperature 
increases, the PDMS mixture becomes cross-linked and solidified and this property of 
PDMS makes it a good material for molding devices. When it becomes solidified, the pat-
tern from the mold (e.g., silicon wafer with pattern on its surface can be used as a mold) 
is replicated to the PDMS surface. For fabricating the silicon wafer for PDMS devices, the 
procedures are shown in Figure 9 that involves photolithography, etching and molding. 
PDMS is used for the molding step to make the bulk of the device. The pattern from the 
silicon wafer is inversely replicated on the PDMS surface (Figure 9 E) [42]. The micro-
scale channels become present on the PDMS surface, for instance, the junction channels 
from the microfluidic device for axon isolation are fabricated in this way. 
For the microfluidic device for neuronal culture, PDMS serves as a very suitable 
material. The junction channels from the microfluidic device can isolate the axon from 
the neuronal soma and this gives the microfluidic device a big advantage for neural cell 
culture compared to normal culture dishes (Figure 10)  [119, 121, 84]. Microfluidics 
technology has already been widely applied in cell morphological studies and it has be-
come an innovative culture device to build compartmentalized neuronal culture for neu-
roscience studies. For neurite isolation by the microfluidic device, different lengths of 
junction channels can be used to distinguish the dendrite and axon because of the faster 
growth and greater length of the axon compared to dendrite [34]. Longer junction chan-
nels (>300 μm) can distinguish the axon from the dendrite. The junction channels with 
small cross-section have a smaller volume compared to the large channels, which also 
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makes them a barrier between two compartments to slow down the chemical diffusion 
effect between two compartments. 
 
 
 
 
 
Figure 9: Schematic fabrication process of a microfluidic device made of PDMS for neuronal culture.  The 
double photolithography steps create two different heights of channels. The first photolithography 
makes the junction channel, and the second photolithography makes two big compartments. Reprinted 
from [146] with permission 
 
 
Figure 10: Microfluidic neural culture platform.  (A) Perspective picture of the PDMS device with two 
chambers (black and yellow) which are connected by many junction channels (10 μm in width and 3 μm in 
height, 450 μm in length) to let the axon to grow through. (B) Side view of the device. The cell soma is 
isolated on the left side of the junction channel and only the axon (in red) grows through the junction 
channel and reaches at another chamber. Reproduced from [144] with permission 
A 
B 
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1.2.5 Microfluidic device for AD studies 
Benefitting from the compartmentalized chambers and the neurites isolation de-
sign, microfluidic device has been used for neurodegenerative diseases studies, including 
AD studies. In AD, the disease spreads from one region to another in the brain. Tau pa-
thology has evolved in the same predictable pattern as the early neuropathological de-
velopment of AD [17]. There is a hypothesis stating that the local Tau aggregation can be 
transmitted from neuron to neuron, which plays an important role in the progression of 
Tau pathology [36, 109]. It was also reported that the secretion of Tau by presynaptic 
neurons and its uptake by postsynaptic neurons could be the sequential events leading to 
the propagation of Tau pathology in the brain [109]. This indicates that the axonal trans-
portation participates in the disease propagation. These neuron-to-neuron and presyn-
aptic-to-postsynaptic models can be simplified and built into microfluidic devices with 
compartments by using the junction channels to distinguish the axonal network from the 
whole neuronal culture, in order to exclude the other factors that also potentially to con-
tribute to AD propagation and focus on the axonal transportation for Tau pathology stud-
ies.  
In 2011, Anja Kunze used a compartmentalized microfluidic device to build a co-
pathological model for Tauopathy study (Figure 11) [85]. In this model, a diseased cell 
population communicated with a healthy cell population from another compartment 
through culturing their axons in the same compartment, which was isolated from the two 
cell population compartments. The diseased cell population was induced by okadaic acid 
(OA), an inhibitor of Tau dephosphorylation. As an example, OA infused into the right 
lateral dorsal hippocampus area of ovariectomized adult rat induced NFTs-like AD pa-
thology in vivo [158], which we replicated in vitro. During the drug exposure, OA diffused 
through the junction channel and created a gradient in the middle channel where axons 
were growing (Figure 11 A). As a result, the OA-induced cell population exhibit hp-Tau 
aggregates in the neurites and the soma. The axonal network under gradient exposure of 
OA presented different phosphorylation states (Figure 11 B). The un-exposed cell popu-
lation revealed a homogeneous Tau distribution and hp-Tau was heavily increased after 
24 h. All these results demonstrate that a novel experimental model to generate co-
pathological states within two separated primary cortical cell compartments that are 
connected through a neurite network. This device opens the possibility of study cellular 
and molecular propagation mechanisms in neurodegeneration in Tauopathies (e.g., in 
Alzheimer), as well as simultaneous drug effects on connected healthy and diseased cell 
populations. 
Building a co-pathological neuronal network in a compartmentalized microfluidic 
device has been proved as an appropriate simplified model to mimic the disease propa-
gation in vitro. It is reasonable to continue using this model for neurodegenerative dis-
ease studies. This microfluidic device could also integrate with other microdevices to 
investigate more characteristics of AD during disease propagation. For example, a re-
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cording device could be added to observe the electrophysiological alterations besides the 
morphological observations from the microfluidic device. This will help us to understand 
sequential occurrences of structural and functional change, which will potentially pro-
mote research on AD early diagnosis. 
 
 
1.3 Electrophysiological studies  
1.3.1 Development of technologies for neural activity recording 
Besides the morphological characteristics, electrical properties play an indispensa-
ble role in living beings, from a single ion channel on the cell membrane to whole organs 
like the heart.  In 1939, Prof. Andrew Fielding Huxley first started to study the squid gi-
ant axon, and with the large nerve fibre from the axon, he found keys to understanding 
the electrical activity that excites biological cells which had been a mystery since the 18th 
century [45]. Kenneth Cole and George Marmont invented the first voltage clamp and the 
first experiments with this equipment were made in 1947 [65]. They made an internal 
 
Figure 11: Images of primary cortical neural network in compartmentalized PDMS microfluidic device 
after OA treatment.  (A) Differential interference contrast (DIC) image of the primary cell culture in the 
microfluidic device before OA treatment (B) Immunocytochemical staining image of primary cortical 
neurons in the microfluidic device after OA treatment (600 nM) for 75 min on the left cell population. 
(Green: CY-2, blue: DAPI) Reprinted from [85] with permission  
A 
B 
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electrode to be inserted into a squid giant fibre. The current would be fed to the elec-
trode under feedback control and Cole added an arrangement by which alternatively the 
potential of the electrode could be controlled electronically. Based on this voltage clamp 
technique, Prof. Andrew Fielding Huxley established that the ions carry electrical signals 
in nerves (Figure 12) [63, 62], and received the Nobel Prize with Alan Lloyd Hodgkin and 
John Carew Eccles “for their discoveries concerning the ionic mechanisms involved in 
excitation and inhibition in the peripheral and central portions of the nerve cell mem-
brane” in 1963 [45]. At the same time period, microtechnology started to progress and 
the patch clamp technique was invented in the 1980s by Erwin Neher and Bert Sakman, 
which was essentially a more refined version of the voltage clamp [134]. It allowed the 
study of ion channels in a wide range of excitable cells. They won the Nobel Prize in 
Physiology or Medicine in 1991. Meanwhile, new recording technologies were required 
which could be more reliable, have lower noise and higher throughput than the patch 
clamp technology, even though planar patch clamp had been commercialized at that time 
[135]. During the past decades, several technologies have been developed to record the 
action potential, including current clamp, voltage clamp, patch clamp. However, these 
technologies are based on intracellular recording techniques. Compared to the new ex-
tracellular recording technologies, intracellular recording technologies are limited to 
recording individual neurons by inserting electrode into the intracellular environment 
and it is regarded as an invasive method [139]. New technologies that allow for long 
term recording and large number of cells recording are required. Based on the fast de-
velopment of microtechnology in the past decades, new techniques such as microelec-
trode array (MEA) have brought us into a new era in ion channel research. This technol-
ogy of recording extracellular neural activities is applied in this thesis to study the elec-
trophysiological alteration during AD propagation. 
 
 
 
                                             A                                                     B                                                            C  
Figure 12: Intracellular recording of the squid giant axon.  (A) Photomicrograph of an electrode inserted 
inside a squid giant axon (around 500 μm diameter). (B) The first intracellular recording of an action 
potential. (C) Types of microelectrode employed. Images were taken from Hodgkin and Huxley in 1945. 
Reprint from [63] with permission  
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1.3.2 Intracellular recording methods in vitro  
As mentioned previously, it has been a long way to understanding the physiology of 
neural activity and inventing new tools to assist our exploration on electrophysiology.  In 
1947, Kenneth Cole and George Marmont did the first experiment with the voltage clamp 
and detected that the action potential is generated by sodium ions moving down their 
concentration gradient [65]. Voltage clamp measures how much ionic current passes the 
cell’s membrane under a certain voltage and this mechanism is strongly related to the 
natural characteristics of voltage-gated ion channels. This is an invasive method, which 
requires inserting microelectrode inside the cells. Instead of inserting a sharp microelec-
trode inside the cell, the new patch clamp technique applies a glass micropipette tip and 
an electrode together to attach to the cell membranes in different ways (Figure 13) with 
advantages and disadvantages [96]. Intracellular patch clamp and techniques which al-
low direct measurement inside the cell, are still the prime tool to characterize the sub-
threshold synaptic potentials, membrane oscillations and action potentials [139] even 
though they have some limitations (e.g., cell invasion and limited number of cells for re-
cording). The new planar patch clamp has been developed based on patch clamp tech-
nique (Figure 14). It is based on microfabrication technology which provides greater 
than two orders of magnitude increase in throughput compare with the traditional volt-
age clamp techniques [82]. This type of automated patch clamp can avoid a mass of man-
ual work on inserting the electrode for the operators. In general, patch clamp has greatly 
contributed to neuroscientists on intracellular recordings until now, including on Alz-
heimer’s disease studies [67, 136] to illustrate the electrophysiological properties of AD.  
1.3.3 Extracellular recording methods in vitro 
Meanwhile, the noninvasive extracellular recording techniques have been invented. 
Nowadays, substrate-integrated MEAs technique is an innovative methodology in studies 
on neuronal circuit-connectivity, physiology and pathology in vitro and in vivo [139]. 
MEAs technique enables simultaneous recording of the electrophysiological signals and 
stimulation in a neural network from native brain slices or neuronal cultures by a certain 
quantity of recording electrodes [139] for days and months. This recording system com-
bines a neuron, a cleft between the neuron and the substrate, and the recording elec-
trode at bottom to monitor and stimulate the activity (Figure 15). The obtained signals 
are amplified by the amplifier and sent to the data acquisition system for further analy-
sis. The substrate is coated with chemicals depending on the cell type for cell adhesion 
like in a normal culture dish.  Figure 16 and Figure 17 present some basic concepts of 
neuronal activity, e.g., spike and burst, from the MEA recording. 
Complementary metal oxide semiconductor (CMOS)-based MEA can achieve higher 
signal resolution by increasing the number of the electrodes (e.g., 16,384 electrodes per 
MEA [88]) and reducing the diameter of the electrode tip. It allows extracellular record-
ings at a very high spatio-temporal resolution. By including amplification on the chip it-
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self, noise is minimized and a high signal quality is guaranteed. However, increasing the 
number of neurons results in the need for sorting out the single neural activity from the 
neural network. This is referred to spike sorting, which is a time consuming task [95]. 
This challenge is specially true happened for the MEA device with a huge number of elec-
trodes, such as the CMOS technology [38]. Recent developments in measurement tech-
niques and in spike sorting algorithms help to overcome some of the limitations of extra-
cellular recordings, which enable high-density MEAs (HDMEA) to obtain clear and relia-
ble signals [41].  
 
 
 
 
 
 
Figure 13: Four methods for patch clamp including cell-attached recording, inside-out recording, whole-
cell recording and outside-out recording.  Source: http://www.leica-microsystems.com/science-lab/the-
patch-clamp-technique/ 
 
1. Introduction 
17 
 
 
 
 
 
                                                                A                                                                                                  B 
Figure 14: Schematic of the design of the planar patch clamp system.  (A) A single chamber showing the 
compartments and a cell. Cell is loaded into its chamber and negative pressure is applied to pull the cells 
into the holes to form high-resistance seals like the “tip” from the patch clamp. The membrane within the 
hole is subsequently mechanically, electrically or chemically perforated to obtain a whole-cell recording 
configuration. (B) An array of three chambers. An actual array might have between 2 and 384 wells. 
Reprinted from [6] with permission  
 
                                                                            A                                                                                  B 
Figure 15: Theory of MEA recording and an example of MEA device.  (A) Schematic layout depicting the 
spatial relationships between a neuron and a substrate-integrated electrode and the analogue passive 
electrical circuit. Reprinted from [139] with permission. (B) Scanning electron microscope images of 
neurons grown on a matrix of gMμEs. Reprint from [116] with permission 
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Comparing the CMOS-based MEA to our glass-substrate based MEA, our device 
cannot allow large numbers of electrodes. However, the material used for CMOS is 
opaque and it cannot be used with inverted microscopy technology. MEA devices are fab-
ricated on a transparent glass substrate, which means it is more compatible for micro-
scope imaging than a CMOS device. This transparency is a particular indispensable prop-
erty for our integrated microsystem that aims synchronous for morphological and elec-
trophysiological observations. At the same time, our glass-substrate based MEA is more 
flexible and fabrication costs are lower. 
 
Figure 16: Neuronal network on a microelectrode array (MEA) device and the illustration on the basic 
concepts of electrophysiological activity.  Reproduced from [114] with permission 
 
 
Figure 17: The illustration of spike train and burst train with an example of a raw signal.  Reproduced 
from [114] with permission 
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Another important property of the recording device is the signal-to noise ratio [66]. 
There are two main factors that influence the cell-chip coupling: the cell adhesion and 
the input impedance of the electronic interface [12]. A large sealing gap between the re-
cording neuron and the electrode increases the resistance and decrease the signal ampli-
tudes [133]. The electrode itself with a big impedance can lower the signal quality as well 
[12]. These are the reasons that other shapes of 3D electrodes have been developed, e.g., 
the gold mushroom-shaped microelectrodes (gMμEs) (Figure 15 B) [54]. These gMμEs 
electrodes enable simultaneous electrical recordings from many individual neurons at a 
quality comparable to intracellular recordings by sharp or patch electrodes. 
1.3.4 Microelectrode array recording technology 
Microelectrode arrays (MEAs) technology is an extracellular recording and stimula-
tion technology based on microtechnology. The development of MEA technology started 
from C. A. Thomas Jr. in 1972 (Figure 18) [148]. By using a planar multi-electrode array, 
field potentials from spontaneously contracting sheets of cultured chick cardiac myo-
cytes could be recorded, whereas recording of activity from single cells was not possible 
[129]. Today, MEA devices are used in neuroscience laboratories to characterize electro-
physiological signals from either natural brain slices, or in vitro neural networks from 
dissociated neurons. MEA recorded data can be analyzed to extract functional connectivi-
ty and functional links in in vitro neural networks using statistical algorithms [43].  
 
The MEA devices we used in this thesis were fabricated in a cleanroom as well as 
the microfluidic device. It contains 60 electrodes, which allow for simultaneous record-
ing from multiple points in the neuronal network. The compatibility of MEA and micro-
fluidic fabrication processes allows us to integrate neural electrophysiological studies 
into compartmentalized microfluidic devices [37]. The pattern of the 60 electrodes is 
 
Figure 18: The MEA device invented in 1972.  (A) The plan view of the completed MEA device which 
contains 30 electrodes. (B) The electrode tips covered with photopolymer insulation [19] 
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adapted to the compartmentalized design from the microfluidic device. Using this device, 
we recorded neuronal activities from the soma area and the isolated axon area. These 
recorded data extend our knowledge of functional alteration during AD propagation, and 
together with morphological data from the microfluidic device, we are able to observe 
the relation between morphology and electrophysiology during AD progression.  
1.3.5 Glass-substrate based MEA device 
Nowadays, 2D and 3D MEAs are being applied in neuroscience studies [60] and 
have shown great potential for in vitro neuronal network studies in neurotoxicity and 
neuropharmacology evaluations [114]. The brain slice with native networks or dissociat-
ed neural cell culture will be simultaneously recorded and response to stimulation for 
long periods without mechanical damage to the plasma membrane [139]. Dissociated 
neuronal networks lacking of many features of a real brain is inevitable, but they still 
retains some other functions. They can develop organotypic synaptic connections and 
exhibit a rich variety of distributed patterns of electrical activity and all these extracellu-
lar signals from the neural network can potentially be recorded by the MEA system 
[129]. 
The electrode array is designed by Clewin Software and fabricated in the clean-
room, containing 60 electrodes (Figure 19 A). Glass is chosen as the substrate material 
for our device because of its transparency, biocompatibility and insulation characteris-
tics [60]. Then it is mounted to a printed circuit board (PCB) by conductive glue which 
transfers the measured signals to the external data acquisition system [60]. Cells are 
placed close to or on the top of a metallic electrode (Figure 19 B) and the electrical field 
around the cell can be recorded [60].  Afterwards, the MEA device is connected with a 
data acquisition system (Multi Channel Systems, Germany) with an integrated amplifier 
and a stimulus generator (Figure 19 C), and this system is further connected to a com-
puter for data visualization and analysis (Figure 19 D). The MC_Rack software (Multi 
Channel Systems, Germany) is installed in the computer and is used for data acquisition 
and analysis. 
The MEA device used in this thesis, it is based on the MEA fabrication technology 
from Qwane Biosciences SA in Switzerland. It is integrated with the compartmentalized 
microfluidic device to obtain additional electrophysiological information during AD 
propagation. We design the pattern of the electrodes from the MEA device adapting to 
the compartmentalized design from the microfluidic device, so that the electrodes are 
located at the compartments for neuronal culture and axonal network instead of the 
junction channels area.  
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1.4 2D and 3D neuronal culture  
1.4.1 Comparison of 2D and 3D neuronal culture environments 
Depending on the objectives of the cell culture experiment, 2D and 3D cell culture 
have their advantages and limitations. It is necessary to select the proper cell culture 
model depending on the objectives of experiments. In AD studies, both 2D and 3D neural 
culture models have their advantages when combined with microfluidic device. Tradi-
tional 2D neuronal culture on the substrates (e.g., glass, plastic surface) can be used as a 
simplified model without producing the anatomy or physiology of a native brain tissue 
[59]. It is more suitable for experiments requiring an axonal network isolation function 
from the microfluidic device, uniform and quick removal of the drug exposure in the ma-
trix for absolute control and better imaging quality. However, some experiments cannot 
be realized in a 2D culture, like tracing extracellular material secreted from the cells, e.g., 
Aβ plaques. 2D cell culture is also not sufficient for drug testing because it does not really 
present the drug efficacy and toxicity compared to a real tissue. 3D scaffolds can provide 
the intricate cell-cell and cell-environment interactions and better mimic the structure 
and mechanism property of the brain tissue. Neurons are a type of process-extending 
cells with outgrowth in all directions, and 3D scaffolds lead to longer neurite outgrowth, 
higher density of cells and neural network formation, higher cellular survival, more real-
istic gene expression and cellular behaviours [89]. By entering the third dimension, cells 
in the artificial scaffold will have relatively comprehensive external conditions, like mul-
tiple extracellular matrix (ECM), mechanical stimulation, soluble signals from neighbour 
and remote cells [52]. This requires the organization of the cells and the nutrient and 
waste product exchange [59] which brings complexity into the experiment and  makes it 
less convenient for manipulation. 
1.4.2 3D neuronal culture 
In 3D cell culture, the scaffold material and architecture will determine the effective 
mechanical and mass transport properties that can significantly influence tissue regen-
 
               A                                        B                                              C                                                           D  
Figure 19: The manipulation of the MEA recording system.  (A) The design of the board of 60 electrodes 
MEA. (B) MEA device for cell loading. (C) Recording system with amplifier and stimulus generator. (D) 
Window of data visualization and analysis system from a computer (60 electrodes for 10 minutes record-
ing) 
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eration [70]. For neuronal culture specifically, the ECM influences diverse mechanisms 
including mechanical or adhesive interactions and charge interactions via electrically 
charged ECM components [31]. The relation between properties of the ECM and the neu-
ral functions is still not fully understood. So far, the choice of bulk materials used for 3D 
scaffold includes metals, glasses, polymers, and ceramics [58]. Polymers are the most 
popularly applied materials due to the feasibility to control their chemical and structural 
properties.  Both synthetic and natural derivatives polymers play vital roles in tissue en-
gineering since 1980s [156]. Synthetic polymers include poly(ethylene glycol)(PEG), poly 
glycolic acid (PGA), poly lactic acid (PLA) and poly(caprolactone) (PCL) [126] and so on. 
Natural polymers include collagen, gelatin, elastin, silk fibroin, chitosan, chitin, fibrin and 
fibrinogen [132] and so on. In order to choose a proper material for a scaffold, several 
parameters need to be considered, including fabrication, architecture, mechanical prop-
erties, biocompatibility, and biodegradability [21, 70]. Specifically, architecture is defined 
to include pore shape, pore size, and pore interconnectivity which interrelate strongly 
with scaffold characteristics.  
Agarose hydrogel is widely used in tissue engineering for cell immobilizations and 
it has the necessary physiochemical structure to support 3D neurite extension from pri-
mary neural cells. Compared to collagen, agarose has shown better result for cell survival 
and neural outgrowth, and it can provide better stiffness to mimic a soft organ such as 
brain which is near 260-490 Pa [108, 94, 115]. The 0.5 % (w/w) agarose gel we apply for 
our 3D culture has the stiffness between 2 kPa and 5 kPa, while the stiffness of a typical 
concentration of collagen is above 10 kPa [157]. For experimental manipulation with gel, 
the curing temperature and duration is another important factor. Agarose has short tran-
sition time and its mechanical properties are independent of the speed of the curing pro-
cess. It takes less than 10 s. to cool down some preheated agarose, while collagen is re-
ported to take more than 30 min following a standard protocol [13, 157]. However, using 
agarose alone does not provide good neuronal survival [115], it is necessary to add other 
factors to promote the neural growth or neurite outgrowth. Alginate is a natural polymer 
derived from algae and it is a linear polysaccharide composed of (1-4)-linked β-D-
mannuronic acid (M) and α-L-guluronic acid (G) [10]. It has been shown that alginate 
hydrogel strongly supports the neurite growth and protects the neurons against oxida-
tive stress [106]. The combination of agarose and alginate will become a proper scaffold 
to build 3D neural culture in microfluidic device. 
Some hydrogel-free methods have been developed in addtion. For example, 3D 
neural networks built with silica beads was reported by Sophie Pautot in 2008 (Figure 
20) [125]. Primary rat hippocampal neurons were cultured on micro-beads (several doz-
en microns in diameter) made of silica that provides a growth surface. Like a normal cell 
culture dish, the surface of the silica bead was treated with poly-L-Lysine (PLL) coating 
solution to enhance the cell adhesion and support neural maturation. Meanwhile, some 
other beads were treated with attractant signalling molecule cyclic AMP (cAMP) to guide 
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the axonal growth [138]. The axon grows at a speed 50 μm/d over the cAMP coated 
beads surface. They managed to guide process extension from one population of neurons 
to another by inserting guiding beads in the assembly. It was proved that these micro-
beads can be used as carriers for the cells and allow for neural growth, neural matura-
tion, transfection and manipulation. This method brings more flexibility for cell manipu-
lation than the hydrogel-based ones. Based on this 3D beads-culture technology, we ex-
plore culturing primary cortical neurons on these silica beads and pattern them inside a 
compartmentalized microfluidic device to mimic the layer pattern in cortex. At the same 
time, we also consider the shortcomings of commercial glass particles and try to use soft 
microgel particles (MGPs) instead [127]. We further develop our micro-beads with aga-
rose-alginate gel inspired by the Hanging Drop Arrays technique (Figure 21) [150]. Our 
gel beads can provide a portable 3D scaffold for brain studies. Together with microfluidic 
device, we manipulate the gel-beads and build layer pattern 3D culture. 
1.4.3 3D neuronal culture for AD studies 
The conventional 2D culture has some drawbacks for AD studies. For instance, se-
creted Aβ can continuously diffuse into the culture medium instead of being aggregated 
and form Aβ plaques in 2D culture. 3D culture can avoid this problem because of its solid 
scaffold. It is reported that 3D culture would accelerate Aβ deposition by limiting diffu-
sion of Aβ, allowing for aggregation [24]. In 2015, the characterization of a novel 3D cul-
ture system was reported which exhibits key events in AD pathogenesis, including extra-
cellular aggregation of Aβ and accumulation of hp-Tau. This is the first human cellular 
model that showing the Aβ driven Tauopathy in 3D culture comprehensively. This model 
can be used to examine many other key questions of AD pathogenesis in vitro, including 
the molecular mechanisms underlying the production of high concentrations of Aβ, the 
accumulation of extracellular Aβ, the deposition of Aβ aggregates, the hyperphosphoryla-
tion of Tau and hp-Tau aggregation. More conditions can be tested under controlled con-
ditions in this 3D AD model. For instance, microglia cells can be added to study its crucial 
effect in Aβ clearance, brain inflammation and synaptic and neuronal damage [100]. 
Overall, this is a big advance on building 3D neural cell culture model for AD studies. 
More important characteristics from the real AD brain should be added to mimic the 
brain comprehensively, and this may have an effect on the results. 
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For 3D cell culture, compartmentalized microfluidic device can be used for the con-
struction of brain models [32] mimicking some specific patterns in the brain. In 2011, 
Anja Kunze reported a 3D layer hydrogel scaffold mimicking the layer structure of cortex 
inside a microfluidic device (Figure 22) [83]. This work intended to control laminar flows 
of agarose-alginate gel with and without primary cortical neurons, and freeze the hydro-
gel when it achieved the multi-layer pattern. In order to build layer-pattern in the micro-
fluidic device, flow-controlling system was required for the laminar flow in microfluidic 
device. Rich experience is required with this work because of the gel solidification under 
temperature variations and laminar flow control by a pump that makes it more difficult 
on gel manipulation. This is a successful model of mimicking brain structure by combin-
ing hydrogel culture and microfluidics technology. This 3D cell culture model can be used 
 
                                                                                 A                                                                          B 
Figure 20: Schematic image of the guidance concept of 3 layers beads.  (A) On layer 1, 2D neurons are 
growing on the coverslip and their axons (in blue) are growing throw the Layer 2 cAMP coated beads. 
The GFP-expressing neurons from beads Layer 3 descend their dendrites (in green) down through the 
Layer 2 beads and encounter the extended axon from 2D neurons on Layer 1.  (B) Image of the 3D recon-
struction neural network described in Figure A. Reprinted from [125] by permission  
 
 
Figure 21: Schematic picture of the hanging drop formation process.  (A) and the humidification chamber 
used to culture 3D spheroids in the hanging drop array plate (B). Reproduced from [150] with permis-
sion 
A 
B 
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for AD studies by patterning cell layers in the microfluidic device to observe cell-cell and 
cell-environment interactions during disease propagation.  
In this thesis, the microfluidic device with layer patterning design is combined with 
the 3D beads culture including silica beads and agarose-alginate beads. This layer-
pattern 3D neuronal culture model using microfluidic device mimicking the cortex struc-
ture that has layers of different compositions, can be used to study the neuron-to-neuron 
interactions in an in vitro 3D environment. This will represent a novel model to study 
neurodegenerative diseases including AD. 
 
 
 
1.5 Building an AD propagation model 
1.5.1 Concept of co-pathology in building AD propagation model 
During disease progression, neurons from different regions in an AD patient’s brain 
have abnormal functions and these regions probably affect each other through the neural 
networks. NFTs and Aβ, two major hallmarks in AD, are very likely involved during this 
propagation in the neuronal network between different brain regions. During the devel-
opment of AD, NFTs follow the pattern of disease spreading in the brain, from the tran-
sentorhinal cortex, followed by the hippocampus and cortical areas. There is evidence 
that the local Tau aggregation can be transmitted from neuron to neuron through synap-
tic connections, which is an important role in the progression of Tau pathology [36, 109, 
16]. Aβ does not follow this spatiotemporal propagation pattern in the brain, however, 
 
                                                A                                                                                                B 
Figure 22: Designing principle of the 3D layer hydrogel scaffold for neural cell cultures.  (A) Image of a 
native cortical brain slice showing the six different cell layers after staining for cell bodies and closed 
dendrites. The engineered model consists of two cell layers interlaced by two cell-free layers. (B) Sche-
matic drawing of the layer structure of the 3D neural cell culture. There are 4 inlet channels for gel load-
ing, through the main channel and exit the outlet channel. The two inserts show the final microfluidic 
device and three devices placed in a Petri dish for incubation during cell culture. Reprinted from [83] 
with permission  
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the soluble oligomeric Aβ is still direct transferred from neuron to neuron [113]. It be-
comes obvious from the evidence above, that transportation from neuron to neuron 
plays an important role in the neuronal network. We call the the pattern of the diseased 
and healthy neuronal populations with interaction a “co-pathological” model (Figure 23). 
In this model, two neuronal populations grow separately, while their axons are connect-
ed and the disease spreads from the diseased neuronal population towards the healthy 
one. In order to focus on the axonal transportation during disease propagation, the axon-
al network needs to be distinguished from the other parts of each neuronal population to 
exclude some other possibilities on transportation. First, two neuronal populations are 
cultured separately while the axons from each cell population can grow out of their own 
environment. Afterwards, the axons from each cell population grow into another isolated 
environment and meet there. In the end, one of the two cell populations is treated with a 
drug to induce a diseased cell population model while the observations on the disease 
spreading continue. This co-pathological model with only axonal interactions helps to 
isolate the axon interaction spatially and enables us to study the axonal transport func-
tion separately. To achieve this goal in real experiments, comprehensive designs for ex-
periments and multifunctional devices for targeted characteristics are required for the-
ses in vitro studies.  
1.5.2 Co-pathological model in microfluidic and MEA platforms to 
study AD 
1.5.2.1 Example of co-pathological model in microfluidic platform for AD stud-
ies 
Microfluidic devices for neuronal culture application provide compartmentalized 
chambers that allow 1. the neurons to grow in different regions with precise local control 
of medium and drug, and 2. the axonal network to be isolated by the junction channels 
from the cell soma and dendrites to observe the axonal transport. Benefitting from this 
compartmentalized design of the microfluidic device, we build a co-pathological model of 
diseased and healthy neuronal populations in separated compartments in the microfluid-
ic system, to create the neuron-to-neuron interaction. By using the junction channel from 
the microfluidic device for neuronal culture in general, the axons from the diseased and 
healthy neuronal populations are isolated in to another compartment, so that providing 
an environment that the axons from the diseased neuronal population can communicate 
with the axons from the healthy neuronal population.  
The approach for our compartmentalized microfluidic device was presented by An-
ja Kunze in 2011 [85] as mentioned before in this thesis. This microfluidic device con-
sists of three parallel compartments, each of the two-neighboring compartments are 
connected by small junction channels. Neurons are plated in the two lateral compart-
ments and the axons grow through the junction channels into the middle compartment 
forming a neuronal network. One population was drug-induced to become a diseased 
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neuronal population. To detail the microfluidic device manipulation and drug exposure, 
the liquid from the lateral compartments were removed first, and then the drug-enriched 
medium was injected into the inlet of the left lateral chamber to induce the cells and 
make them become diseased neuronal population. The outlet of the chamber was kept 
not filled. For the right lateral compartment, fresh normal neural culture medium was 
injected to the inlet of the right side lateral compartment. A time variant flow generates 
inside each lateral compartment because of the pressure difference between the inlet 
and outlet. During the time variant flow, a concentration gradient established across the 
main chamber and through the junction channels (Figure 23). The drug exposure lasted 
for 75 min and okadaic acid (OA), as a phosphatase inhibitor of the serine/threonine 
(Ser/Thr) phosphatases that can induce hyperphosphorylation of Tau protein (Figure 
24) [75], was used for drug-induction at 600 nM. The sample was fixed at 6 h after the 
drug exposure. In the left chamber where cells were treated by OA, it was observed that 
hp-Tau aggregation in the neurites and accumulation in the soma on the diseased cell 
population side using Ser262-Tau immunostaining (Figure 25 A). On the contrary, in the 
right chamber, the Tau distribution in the cells has lower fluorescence intensity and no 
accumulation (Figure 26 B). This was the first 2D in vitro co-pathological model on ob-
servations on neurodegenerative disease propagation in a compartmentalized device 
and it opened the possibility to study cellular and molecular propagation mechanisms of 
neurodegeneration in Tauopathology in a microfluidic device.  
1.5.2.2 Our co-pathological model in microfluidic and MEA platforms for AD 
propagation studies 
Inspired from Anja’s co-pathological model above, we decide to continue this co-
pathology arrangement with the diseased and healthy cell populations and their isolated 
axonal network (Figure 26). At the same time, based on our hypotheses on neuron-to-
neuron transmission and axonal transmission during disease study, we build our micro-
fluidic device.  
Compared to Anja’s previous experiment using a gradient in the compartment for 
axonal network, we try to avoid this gradient by continuously replacing the drug in the 
compartment with fresh culture medium. In this way, we can exclude the fact that the 
axons are affected by a gradient of drug in the same compartment and furthermore en-
sure an unexposed environment for the healthy cell population. A publication showed 
much lower concentrations (1.5, 3, 6.25, 12.5, 25 and 50 nM) of OA can induce Tau phos-
phorylation [102], so additionally, we intend to try a lower concentration in our experi-
ment as well as the concentration that was previous used (600 nM) to observe the differ-
ent drug effect at different concentrations. One of our hypotheses is that under low con-
centration OA, the disease could propagate more slowly compared to the high concentra-
tion condition and it is highly possible that we observe more information that is detailed  
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                      A                                                    B                                                  C                                                    D 
Figure 23: The schematic pictures on the experimental region inside a microfluidic device to show the 
steps to achieve a co-pathological “diseased” and “healthy” neural network.  (A) PDMS microfluidic device 
with three compartments connected by junction channels. (B) Neurons were injected inside the two 
lateral chambers. (C) After 1 week continuous culture, the neurites grew through the junction channels 
and build up a neurite network in the middle chamber. (D) The left neuronal cell population was exposed 
to a drug and this will generate a drug gradient in the middle chamber by diffusion through the junction 
channels, while keeping the right cell population unaffected 
 
Figure 24: Microtubule-associated Tau protein equilibrium in the brain.  By phosphorylation, Tau protein 
becomes hp-Tau, and after dephosphorylation, it comes back to be normal Tau protein. When OA is in-
duced to the cells, it inhibits the dephosphorylation of the phosphorylated Tau. Then the phosphorylated 
Tau becomes hp-Tau and highly accumulated inside the brain which is a hallmark of AD 
 
                                                         A                                                                              B 
Figure 25: Fluorescent images of healthy and diseased cells after OA treatment.  (A) Diseased cell from left 
compartment and (B) Healthy cell from right compartment from same microfluidic device with Immuno-
cytochemical staining. (Green: Ser262-Tau, blue: DAPI). Diseased neurons presented accumulation of 
phosphorylated Tau clusters in neurites (arrow 1) and soma (arrow 2). Reprinted from [85] with permis-
sion 
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in the neuronal soma and axon under slower disease propagation. More observation time 
points and longer observation times are added in our experiment compared to previous 
work. In addition to the morphological observations from the microfluidic device, elec-
trophysiology observations are achieved by MEA recording technology as well. In this 
way, we can analysis the alteration of neural activities and obtain the sequential occur-
rence between structural and functional alterations during AD propagation. By adding 
the MEA device into our experiment, it is required to have a more mature neuronal net-
work (>14 days neuronal culture) to allow us to record the neural activities. That is one 
of the reasons that we drug-induce the neuronal population on the 21 DIV instead of 8 
DIV from previous experiment. Another difference is that our junction channel is de-
signed with 500 μm length to further isolate the axon from the dendrite. It can better 
isolate the medium from the compartments as well. However, the axon will take longer 
time to grow out of the junction channels than the 150 μm from the previous device. To-
gether with the microfluidic and MEA platforms we fabricated, a co-pathological AD 
model was built with diseased and healthy interaction in the neuronal network to study 
the AD propagation. All these modification to the device will assist us to prove our hy-
potheses and have a better understanding of AD propagation in Tauopathy. 
 
 
 
 
Figure 26: Schematic picture of the simplified model of AD propagation 
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1.6 Scope of the thesis 
 Based on the microfluidic and the MEA technologies, scientists were able to fabri-
cate PDMS devices and MEA devices individually to do compartmentalized neuronal cul-
ture and record the neural activities respectively. In previous work [85], a microfluidic 
device was developed and applied to build a co-pathological model and mimic some 
characteristics of AD for disease propagation studies. The early stage of hyperphosphory-
lated Tau (hp-Tau) spreading was observed in the drug induced diseased cell population. 
MEA device has been applied in general AD studies for extracellular neuronal activity 
recording as well, but it has not been utilized in AD progression studies [47].  
  In this thesis, we preserve this co-pathological pattern for AD propagation.  We 
combine these two microtechnologies (microfluidics and MEA) together and fabricate 
our integrated microfluidic-MEA device. The microfluidic device part can provide com-
partmentalized channels to extract the axonal network for individual culture and drug 
exposure. We observe the hp-Tau propagation from the diseased cell population to the 
healthy cell population through the axonal network. This proves our hypotheses on the 
neuron-to-neuron transmission, axonal network communication and concentration-
dependent effect of drug during AD propagation. The MEA recording device provides 
electrodes at the bottom of the microfluidic channels to record from the neurons growing 
in the microfluidic channels. This integrated microfluidic-MEA device allows us to ob-
serve time-dependent alterations in neuronal morphology and electrophysiology syn-
chronously during AD progression. This helps us to understand the order in which the 
structural and functional alterations occur (order of occurrence) during AD progression. 
This microfluidic-MEA device is promising in studies of neurodegenerative disease 
mechanism. AD, as a neurodegenerative disease and the most common type of dementia, 
is an appropriate disease example to start to test our microfluidic-MEA device.  
 Some detailed preparative and exploratory work is presented as well, including 
developing 2-dimensional (2D) and 3-dimensional (3D) neural culture in microfluidic 
devices as well as our microfabrication technique for microfluidic and MEA devices and 
the bonding technology for microfluidic–MEA devices. 
 
1.7 Thesis structure 
 In this thesis, the whole process for preparing, fabricating and applying microflu-
idic and MEA techniques for hp-Tau propagation studies of AD is presented.  
In Chapter 2, we present the fabrication methods of microfluidic and MEA devices 
and the bonding method for making the microfluidic-MEA device. This bonding method 
involves the bonding between the PDMS material from the microfluidic device and the 
SU-8 material from the surface of MEA device. After the quantified bonding tests from 
surface analysis and tensile strength test, we find the key factors for this irreversible 
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bonding method between PDMS and SU-8. This bonding method solved our challenges in 
integrating the microfluidic and MEA device. The theory of this bonding method is ex-
plained and this bonding process is detailed in the fabrication of microfluidic-MEA device 
part. The preliminary neural culture and neural activity recording test from this microflu-
idic-MEA device are presented as well. 
 Chapter 3 is the core chapter in this thesis. It presents the experiment of applying 
the integrated microfluidic-MEA device for morphological and electrophysiological ob-
servations during the propagation of AD. The results give us more clues about the phe-
nomenon during neural network degeneration as well as the relation between morphol-
ogy and electrophysiology during AD progression. This work provides valuable observa-
tions and confirms our hypotheses on the neuron-to-neuron transmission, axonal net-
work communication, concentration-dependent effect of drug and the order of occur-
rence of structural and functional alterations during AD propagation. This highlights the 
advantages of the microfluidic and the MEA technologies. 
After the experiments of 2D neuronal culture in microfluidic and MA devices, 
Chapter 4 presents some exploratory work on the 3D neuronal culture in microfluidic 
device. Neurons are cultured on/in two different types of micro-beads (silica and aga-
rose-alginate) and they are patterned into layers inside the microfluidic device to build 
3D neuronal cultures mimicking the layer pattern from the cortex. By culturing neurons 
with the beads, cell sedimentation, which is caused by gravity during the gel solidifica-
tion, can be avoided, and the distribution of the neurons inside the microfluidic device is 
relatively homogeneous. These 3D silica and agarose-alginate beads culture models in 
microfluidic device with layer pattern can be used for cell patterning in 3D environment. 
For AD studies, these two methods will allow us to build co-pathological in 3D mimicking 
the disease propagation and observe the formations of the NFTs and the Aβ plaques that 
might not achieve in 2D neuronal culture. 
Finally, Chapter 5 concludes the work we have achieved so far on morphological 
and electrophysiological observations during AD propagation with microfluidic and mi-
crofluidic-MEA devices. It gives some perspectives for the study of AD propagation using 
microfluidic and MEA devices as well as the concepts of building a brain/cortex-on-a-
chip, like other organ-on-a-chip projects. We are attempting to build a “brain-on-a-chip” 
using microfluidic and MEA platforms, which may potentially make significant contribu-
tions to disease studies and pharmaceutical tests.  

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“If I have seen further it is by standing on the shoulders of giants.” 
by Isaac Newton, in a letter to Robert Hooke in 1676 
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2.1 Introduction 
2.1.1 Integration of microfluidic device and MEA device 
Based on our hypotheses about importance of neuron-to-neuron transmission, axonal 
network communication and concentration-dependent effect of drug during AD propagation, 
compartmentalized microfluidic device can serve as a suitable tool to assist us to investigate 
on these assumptions by building a simplified co-pathological disease propagation model for 
in vitro morphological alteration observations. Meanwhile, the MEA neural activity recording 
device allows for non-invasive simultaneous recording on neuronal culture. This MEA device 
brings great help to understand the electrophysiological signals alteration during AD propaga-
tion.  Together with the compartmentalized microfluidic device, an integrated microfluidic-
MEA device is built (Figure 27 A) which can provide compartmentalized neuronal culture, 
record and distinguish neural activities from different locations in the neuronal network. This 
will help us to observe electrophysiological alterations in the co-pathological model and per-
ceive the sequential occurrences on the structural and functional degeneration during AD 
propagation, which will potentially promote the research on AD early diagnosis. 
This microfluidic-MEA device combines a compartmentalized microfluidic device made 
of PDMS and a MEA device with a 5 μm layer of SU-8 as an insulation layer on the top of the 
wires for recording electrodes and glass substrate (Figure 27 B). In order to integrate the mi-
crofluidic device that is made of PDMS and the MEA device which has SU-8 on its top, the irre-
versible bonding technique for PDMS and SU-8 is required. 
 
2.1.2 PDMS and SU8 
PDMS is an elastomeric material that is widely used for rapid prototyping microfluidic 
systems and cell-chip devices, due to its chemical inertia, thermal stability, permeability to 
many gases, simple preparation, optical transparency, and low cost [105]. It can be easily in-
tegrated with electrodes, heaters, and sensors, which are fabricated on substrates, to generate 
multifunctional devices for biomedical applications [42]. SU-8 is an epoxy-based negative 
photoresist initially developed for the microelectronics industry [98]. Currently, SU-8 be-
comes widespread in the development of microfluidic devices due to its ease of use, the high 
aspect ratio it allows to create, its high chemical stability, and mechanical properties [19]. It 
has become a material of choice for microelectromechanical systems (MEMS) and microfluid-
ics, from the fabrication of single components to complete lab-on-chip devices [2]. Since PDMS 
and SU-8 are both popular materials in the microfabrication field [42, 98], researchers have 
started to integrate PDMS and SU-8 together more and more to benefit from both of their ad-
vantages [122, 123, 117]. In the fabrication of microfluidic devices made of PDMS, the PDMS 
component is generally bonded to a glass coverslip to obtain closed microfluidic channels by 
using an oxygen (O2) plasma surface treatment on the PDMS and glass surfaces. This results in 
a permanent covalent siloxane (Si-O-Si) bond between the PDMS and glass surfaces. However, 
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using O2 plasma is not sufficient to bond PDMS and SU-8 surfaces irreversibly as the oxidation 
of the SU-8 surface does not result in the creation of -SiOH groups. 
2.1.3 PDMS and SU8 bonding methods 
Recently, different bonding methods for PDMS and SU-8 have been reported in the sci-
entific literature, such as nitrogen plasma treatment [160]or spin coating SU-8 on the PDMS 
surface [122]. Nevertheless, nitrogen plasma is not available in all labs, and spin coating, 
which requires layer-by-layer processing during device fabrication, does not provide the flex-
ibility of bonding two fabricated individual devices. Some researchers also choose to bond 
PDMS and SU-8 reversibly [76]. However, for long-term cell culture devices where liquid leak-
age is to be avoided during the whole duration of the experimentation, a solid sealing is nec-
essary which reversible bonding cannot provide. Instead of aligning the devices every time 
before each use, in the case of reversible bonding, irreversible bonding can also save time and 
effort on repeating micro-scale design alignment for the devices before each use as this step is 
time-consuming. As it is increasingly demanded of integration between PDMS and SU-8 devic-
es, irreversible bonding of PDMS and SU-8 becomes an important technology. 
2.1.4 Aminosilane-mediated silanization bonding method 
Silanization is one of the widely applied surface modification methods. It generates a 
self-assembled monolayer of alkoxysilane molecule, which has methoxy (CH3O-), or ethoxy 
(CH3CH2O-) groups onto a substrate. Aminosilane, one of the alkoxysilane molecules, has an 
amino (NH2-) group as well. Aminosilane-mediated silanization has been applied on silica sur-
faces as a coupling agent for functionalization due to its bifunctional nature [161]. (3-
Aminopropyl)triethoxysilane (APTES) is one of the highly-selective effective aminosilanes, 
which has been widely applied in bonding materials for microdevice fabrication and protein 
immobilization for biological applications [159, 64, 141]. It has been used for bonding PDMS 
to various thermoplastic materials including polycarbonate  
(PC), cyclic olefin copolymer (COC), polymethylmethacrylate (PMMA), polystyrene (PS) and  
others [143, 142, 141]. SU-8 is an epoxy-based negative photoresist and the epoxy groups that 
remain on the SU-8 surface could be sufficient to react with the aminosilane molecule from 
the PDMS surface and form a covalent bond. In this way, PDMS and SU-8 bonding can be real-
ized by introducing APTES molecules between the two materials (Figure 28). It is promising 
to apply this theory to the irreversible bonding of PDMS and SU-8 for our integrated microflu-
idic-MEA device.  
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Figure 27: Microfluidic-MEA device.  (A) Picture of this integrated microfluidic-MEA device for our neural 
culture bonded with our PDMS and SU-8 bonding method. (B) Schematic of the cross-section of the device 
 
                                                                                                       A 
 
                                                                                         B  
Figure 28: Theoretical reactions during the bonding. (A) Reaction between APTES molecule and the O2 plasma 
activated PDMS surface and (B) reaction between the -NH2 group from the APTES molecule on the PDMS 
surface and the epoxy group from the SU-8 surface. 
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In this chapter of device fabrication, we first describe the fabrication methods of micro-
fluidic and MEA device. Then we investigate on the bonding technique of microfluidic and 
MEA devices, focusing on PDMS and SU-8 bonding technique. We try to find a simple and reli-
able bonding method for PDMS and SU-8, based on the elements and chemical bonds from the 
modified PDMS surface through the XPS analysis and the tensile strength test for the SU-8 
processed with and without a hard bake step. In addition, we detail this bonding method with 
a practical microfluidic device example. This device combines a compartmentalized microflu-
idic device made of PDMS and a MEA neural activity recording device with SU-8 as its insula-
tion layer. We name it a microfluidic-MEA device. The design of the electrode array is adapted 
to the compartmentalized design from the microfluidic PDMS device. This allows us to distin-
guish the neural activity from different cell populations, which can potentially present differ-
ent disease status. Axons can be isolated from the neuronal network and be recorded sepa-
rately. This combination of compartmentalized PDMS device and MEA device provides a mul-
tifunctional platform for neuroscience research. Our bonding technology is used to bond the 
PDMS and SU-8 surfaces irreversibly for this microfluidic-MEA device. The cell compatibility 
of this bonding method is proved through neural electrophysiological results using this inte-
grated device. It is promising to apply this simple and reliable irreversible bonding method to 
integrate microdevices with PDMS and SU-8 surfaces for biological use. This type of microflu-
idic-MEA device has proved an innovative tool for neural electrophysiological studies. 
 
2.2 Methods 
2.2.1 Microfluidic device design and fabrication 
We designed the compartmentalized PDMS device with three chambers (Figure 29). 
Each two chambers are connected by junction channels of 20 μm width, 10 μm height and 500 
μm length. The low dimensions on width and height allow the microfluidic PDMS device to 
segregate the neural soma in one chamber and allow its axon to grow through the junction 
channel to the neighbour chamber. We placed the primary neural cells into the two lateral 
chambers (Region 1 and 3) and the axon from the cells will grew through the junction chan-
nels and built a neural network in the middle chamber (Region 2) with axonal contacts from 
the two lateral cell populations.  
We choose PDMS as the material for our microfluidic device based cell culture. The pat-
tern of chambers and channels on the bottom surface from the PDMS device is molded by us-
ing a silicon wafer (Figure 30). The silicon wafer is fabricated in a cleanroom with a mask that 
has the pattern for the microfluidic device. The mask was designed using Clewin 4 and pro-
duced in the LASER lithography system (Heidelberg DWL200). For the silicon wafer fabrica-
tion, two types of wafer fabrication processes can be used (Figure 31), depending on whether 
different heights are necessary for the channels. In order to isolate the neurites, we need to 
use different heights of channels to make the barriers, for example some low height junction 
channels (e.g., 10 μm in height that is smaller than the size of neuron soma), to block the neu-
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ron soma and let the neurites to grow through to other compartments in the device. In this 
case, junction channels require a different height compared to normal channels, only to let the 
neurites to grow through. A two-step dry etching process can be used to fabricate the wafer to 
mold PDMS device, which requires different heights (Figure 31 B). After the first etching step, 
the channels are 10 μm high for the junction channel. With the second etching step, another 
90 μm high etching is made so that the total channel height becomes 100 μm. Otherwise, if 
junction channels are not applied, one-step dry etching process is enough and all the channels 
are in the same height (Figure 31 A). 
 
 
 
 
 
Figure 29: Designs of microfluidic device and MEA device.  (A) Design of microfluidic device and illustrations. 
(B) Design of MEA device with 60 electrodes in 3 columns in parallel. Scale: 1000 μm 
 
Figure 30: A representative microstructured silicon wafer contains multiple microfluidic designs for PDMS 
master molding.  Scale: 1000 μm 
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Once the silicon wafer is fabricated, it is used as a mold for making PDMS devices. Before 
we use it for molding, we deposit a thin layer of SiO2 to make a protection layer on top of the 
silicon wafer to allow for longer usage as a mold for PDMS device. (Figure 31 B ⑪) PDMS 
sticks to the silicon wafer's surface and the PDMS cannot be peeled easily from the silicon wa-
fer. To solve this problem, a silanization should be done for the silicon wafer surface before 
the first use. This makes the wafer's surface hydrophobic and allows the PDMS to be easily 
unmolded from the silicon wafer. 
After the silicon wafer is ready for PDMS device molding, the next step is to prepare the 
PDMS mixture (Figure 32). The silicone elastomer (PDMS base) and curing agent are mixed 
using a 10:1 ratio (Figure 32 A), then pour the mixture onto the silicon wafer with the pattern, 
up to a height of 5 mm or even higher. Then put the silicon wafer with the PDMS mixture on 
its top into a desiccator (Figure 32 B). The PDMS elastomer can be cured at 80 °C for one hour 
(Figure 32 C). Then the design from the silicon master is molded at the bottom surface of the 
PDMS device. The PDMS part is cut and detached from the silicon wafer (Figure 32 D). The 
opening reservoirs from the device that connect micro channels to the outside environment 
are created by holes puncher tools, and then the device is ready for use (Figure 32 E). Glass 
cover slips of 0.17 mm thickness are applied to close the channels and chambers for the PDMS 
device and to obtain better biological imaging quality. This cover slip bonding is done by an 
Oxygen Plasma treatment for both the PDMS device's and cover slip's surfaces at 40 Pa (300 
mTorr), 50 Watt for 45 seconds. Immediately after this treatment, both parts are pressed 
against each other to complete the bonding process and kept in the oven for 3 minutes. Then, 
the PDMS device is filled with 70 % ethanol for sterile cleaning for 20 minutes, and then 
rinsed by sterile water 3 times to wash away residual ethanol on the surfaces inside the PDMS 
device. UV exposure for 20 minutes is the last step to sterilize the PDMS device and dry the 
chamber inside the device. In summary, after the fabrication of the PDMS device, the PDMS 
device and the cover slip need to be sterilized by ethanol cleaning or by an autoclave machine, 
water washing several times and UV exposure.  
2.2.2 MEA device design and fabrication 
For a normal MEA device for neuronal activity recording, 60 electrodes from the MEA 
device are arranged by 10 rows and 6 columns (Figure 33). For compartmentalized neuronal 
culture, the positions of the electrodes need to be modified. Together with the three cham-
bers, there are two columns of electrodes in parallel in each chamber. These are electrodes 
made of Platinum on the MEA device, which allow for simultaneous recording of extracellular 
potentials from the neuronal culture. At the same time, both the microfluidic PDMS and MEA 
devices were designed to provide a good fitting of their functions and their integration.  
The microelectrodes had a diameter of 50 μm and each two microelectrodes were sepa-
rated by a distance of 200 μm. The fabrication of MEA device was using a process developed 
by Qwane Biosciences SA, Switzerland (Figure 34). First, the glass was cleaned by photoresist 
remover and ultrasound. Secondly, a photoresist layer was spin-coated onto the surface with a 
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thickness of 2 μm for the metal lift-off process. Then a thin layer of titanium (150 Aǒ ) was sput-
tered onto the wafer to serve as an inter-metallic adhesion promoter. Next, a layer of platinum 
(1500 Aǒ ) was sputtered onto the wafer surface. Afterwards, with the ultrasonic removal of 
photoresist, metal traces with electrode and connection pad for external PCB were formed. In 
the end, 5 μm thick SU-8 was spin-coated on top as insulation layer and with no final hard bak-
ing step. The fabricated multi-layered wafer was then diced and assembled with the external 
PCB by a screen printing technique. This MEA device is successfully fabricated in the clean-
room and ready for a further test. 
 
 
 
 
Figure 31: Process flow for microstructuring PDMS devices in the cleanroom.  (A) One depth channel PDMS 
device fabrication process flow: ①Silicon wafer, 10 mm ②Photoresist coating, 5 μm ③Photolithography ④Si 
DRIE etching, 100 μm ⑤Wet oxidation, 300 nm ⑥PDMS molding. (B) Two different depths of channels PDMS 
device fabrication process flow: ①Silicon wafer, 10 mm ②SiO2 deposition, 1 μm ③First photoresist coating, 2 
μm ④First photolithography ⑤SiO2 RIE etching ⑥Second photoresist coating, 5 μm ⑦Second photolithogra-
phy ⑧Si RIE etching, 10 μm ⑨Remove photoresist ⑩Si DRIE etching, 90 μm ⑪Wet oxidation, 300 nm and 
PDMS molding (RIE: Reactive ion etching; DRIE: Deep reactive ion etching) 
 A B 
 
Figure 32: PDMS device fabrication process 
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Figure 33: Design of a normal MEA device with 60 electrodes.  (A) MEA device design by Clewin (B) Close-up of 
the 6 x 10 electrodes array in Clewin software 
 
Figure 34: Schematic diagrams of the fabrication of MEA device.   (A)  A 15 μm thick photosensitive PI film was 
utilized as the substrate for the deposition of metals. (B) A gold layer (2000 Ǻ) was then deposited after a 
titanium layer (200 Ǻ) as the adhesion layer above the PI. Mask 1 was used to create the trace of electrodes by 
wet etching. (C) A gold electrode and pad trace pattern was formed by etching away not wanted metal then 
followed by removing the photoresist. (D) 20-μm-thick spin-coated PI film was used to encapsulate the elec-
trodes.  Mask 2 was then applied to expose microelectrodes and contact pads. (E) MEA device was then baked 
at 100 °C for 1 h. The fabricated MEA device has 60 microelectrodes in total and each active electrode site has 
diameter of 50 μm in circle. Image from my partner Shun-Ho Huang. 
 
(A) 
(B) 
(C) 
(D) 
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2.2.3 Primary cortical neuron dissection 
Our microfluidic system allows culturing a variety of cells of different types (e.g., astro-
cyte, primary neuron) [84], from different regions of the brain (e.g., hippocampus, cortex), or 
from different transgenic animal models (e.g., Amyloid precursor protein transgenic mouse 
models, or tau transgenic mouse models). In our experimental procedure, we cultured disso-
ciated neurons from the cerebral cortex of embryonic mice at day 19 (E19). 
Cortical neurons are dissected from rat embryonic brains and be kept inside Petri dishes 
with PBS solution. Embryonic brain tissue is cut into smaller pieces to avoid clustering after 
digestion. The enzymatic digestion solution (2 ml Segal’s medium with phenol red as pH indi-
cator, add 200 μl papain and drops of NaOH for adjusting pH to 7.3) needs to be heated up to 
37 °C, intermixed with brain tissue at 37 °C for 15 minutes and swirled lightly by hand every 5 
minutes. After the brain tissue settles down, the supernatant is removed and 1 to 3 ml prote-
ase inhibitor solution (10 % horse serum and 90 % neurobasal culture medium, adding 2 % 
B27 supplement and 1 % antibiotics) is added. The brain tissue is then pipetted through a 
1000 μl pipette tip five times to triturate the tissue and the supernatants containing suspend-
ed cells are transferred into a fresh falcon tube through the strainer. Afterwards, the cell sus-
pension is flowed through a 40 μm cell strainer to remove the debris, and some medium is 
then added and centrifuged at 0.6 u/min for 6 minutes. The supernatant is then discarded and 
cells are transferred into an eppendorf tube to count cell density. In the end, the cells are 
transferred into a falcon tube, some 37 °C pre-warmed cell culture medium (neurobasal me-
dium, 2 % (v/v) B27, and 1 % (v/v) GlutaMAX are added and finally can be diluted into the 
desired concentration for the experiment. 
2.2.4 Experimental materials 
PDMS Sylgard® 184 Silicone Elastomer Kit  from Dow Corning Corporation (Midland, 
MI, USA) was sold as two components, the PDMS base and its curing agent. SU-8 (GM 1060) 
was ordered from Gersteltec Sàrl (Pully, Switzerland). (3-Aminopropyl)triethoxysilane 99% 
(APTES) was purchased from Sigma-Aldrich GmbH (Buchs, Switzerland). 
 
2.3 PDMS and SU-8 bonding tests 
2.3.1 Bonding tests 
 2.3.1.1 Bonding theory based on the chemical reactions 
In this irreversible bonding method (Figure 28), APTES molecules, which are both 
CH3CH2O- and -NH2 terminated, are bound both to the PDMS and SU-8 interfaces. The 
CH3CH2O- group reacts with the -SiOH group from the O2 plasma activated PDMS. The NH2- 
group from the other end of the APTES molecule reacts with the epoxy group on the SU-8 sur-
face. Two factors that play important roles during this bonding process were investigated ex-
perimentally: (1) the way the silanization is carried out, either in a liquid-phase or vapor-
phase method; and (2) the degree of reticulation of SU-8 achieved before performing the 
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PDMS and SU-8 bonding step. These two factors have effects on the efficiency of bringing 
APTES molecules on the PDMS surface and the amount of epoxy groups on the SU-8 surface 
after the baking process, respectively. Since the microfluidic device bonded with this method 
will be used for neural cell culture in the future, and the neurons will grow on the surface of 
SU-8, we decided to have the surface modification on the PDMS surface instead of the SU-8 
surface to have less effect on the cell culture. 
For general use of SU-8 on microfabrication, SU-8 is first spin-coated and soft baked at 
low temperature (65 °C to 95 °C) allows evaporating the solvents. Then standard photolithog-
raphy technique is used to reveal the pattern on the SU-8 surface. During the SU-8 exposure 
process of photolithography, the photoacid catalyst facilitates the epoxy group cross-linking. 
Following the exposure, a post exposure bake is performed to selectively cross-link the ex-
posed regions, and the SU-8 resin is developed in a solvent to reveal the fabricated pattern. In 
the end, the SU-8 is generally baked again at 140 to 200 °C for a further crosslink of SU-8 and 
obtains good mechanical properties of the final components. This step is called hard bake. For 
our PDMS and SU-8 bonding, this hard bake step for the SU-8 should happen after the PDMS 
and SU-8 bonding. This is because the hard bake process can further cross-link the remaining 
epoxy groups on the developed SU-8 surface and result in less epoxy group left to react with 
the -NH2 group from APTES molecule. 
 2.3.1.2 Sample preparation for the bonding test 
We prepared our test samples by a combination of PDMS and SU-8 samples under dif-
ferent processed conditions: for the PDMS surfaces, they were first activated by O2 plasma (50 
W, 0.6 mbar, 30 s) to create the -SiOH group on the PDMS surface. After the surface activation, 
the APTES molecules were brought in contact with the activated PDMS surface immediately. 
In the literature, different methods to achieve a surface silanization using APTES have been 
described, such as liquid-phase silanization with deionized (DI) water followed by heating to a 
temperature of 85 °C [81], or by mixing with anhydrous toluene [159] or ethanol [141] and 
vapor-phase silanization [137]. To avoid the use of toxic chemicals, such as toluene [110], and 
provide a bonding method that is compatible with the requirements of the cell culture on a 
chip, we decided to use directly 99 % APTES in liquid-phase or vapor-phase for the silaniza-
tion step. The protocol we used for liquid-phase silanization is the following: PDMS surface 
was immersed for 5 min into 99 % APTES immediately after the O2 plasma, then washed in DI 
water DI water and dried. The protocol for vapor-phase silanization is the following: PDMS 
samples were exposed for 0.5 h or 1.0 h of APTES vapor by placing them into a desiccator con-
taining a few drops of liquid 99 % APTES and reaching a vacuum environment so that APTES 
evaporates. 
To obtain SU-8 surfaces showing different degrees of reticulation, some samples were 
used in the bonding tests without hard bake, while others were submitted to a 2 h hard bake 
at 150 °C on a hotplate. XPS analysis was performed on the surface of the PDMS obtained by 
different silanization methods, including vapor-phase and liquid-phase. The bonding strength 
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was evaluated for different degrees of reticulation for the SU-8, including SU-8 with and with-
out the hard bake process. 
2.3.2 Analysis of chemical reactions on the PDMS  
2.3.2.1 XPS analysis instrument and spectra calibration 
In order to prove the APTES molecules were bound onto the PDMS surface by liquid- 
and vapor- phases silanization, the elements and the chemical bonds on the tested PDMS sur-
faces have been determined by XPS analysis. The samples were analyzed using an ESCA KRA-
TOS AXIS ULTRA Surface Analysis System. Data were analyzed by software MultiPak Version 
9.5 (ULVAC-PHI Inc. Chigasaki, Japan). All spectra were calibrated in reference to the aliphatic 
C 1s component at a binding energy of 285.0 eV.  
2.3.2.2 Evidence of APTES binding to PDMS 
Among all the molecules present in the bonding protocols studies here, the N 1s is only 
present in the -NH2 group of the APTES molecule, so its presence in the XPS spectra proves 
the presence of the APTES molecule on the tested sample. Figure 35 shows the N 1s binding 
energy from different samples: Sample 1 corresponds to a PDMS sample without any chemical 
surface treatment, Sample 2 is a liquid-phase silanized sample under 5 min immersion in 99% 
APTES, Samples 3 and 4 are vapor-phase-silanized PDMS surfaces, exposed for 0.5 h and 1.0 h 
to the APTES vapor, respectively. A peak in the XPS spectra close to an energy of 400 eV cor-
responding to the C-NH2 bond can be seen only for Sample 2, proving the efficiency of the liq-
uid-phase silanization method. No significant peak at this value of the energy can be observed 
for the other samples, which indicate that tested vapor-phase silanization of PDMS is ineffi-
cient in our experiment. Interestingly, the composition measurement of the main elements 
from Sample 2 (C 1s 44.7%, O 1s 30.9%, N 1s 7.3%, Si 2p 17.1%) is very close to the main el-
ements composition of the APTES molecule (C 1s 48.9%, O 1s 21.7%, N 1s 6.3%, Si 2p 12.7%). 
This is a further indication of the presence of the APTES molecules on the surface of this PDMS 
sample after the liquid-phase silanization. 
2.3.2.3 Analysis of the effect after hard bake process on the SU-8 material 
There are typically three heating steps involved during the microfabrication of com-
pounds in SU-8, a soft bake step at low temperature (65 °C to 95 °C) allows to evaporate the 
solvents, a post exposure-bake is performed at temperatures similar to the soft bake step and 
accelerates the SU-8 polymerization, and a hard bake step after development to further cross-
link the epoxy groups of the SU-8 resist. This final baking step result in significant changes in 
the chemical bonds involved and cannot be easily monitored by XPS analysis. After the hard 
bake step, the SU-8 interface has a much higher Young’s modulus [71], a higher stiffness and 
less changes on its shape under strength. On the other hand, the SU-8 without hard bake is 
more flexible and can provide better contact for adhesion [20]. When binding PDMS to SU-8,  
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it is clearly an advantage to have a large number of the epoxy groups on the surface of SU-8, 
and those groups can react with the APTES molecules bound to the PDMS component. To ob-
tain a good binding, the SU-8 and PDMS compounds are maintained in close contact and pres-
sure is applied to the assembling, while increasing the temperature in a similar way as for the 
conventional hard bake of SU-8, which simultaneously favours the binding reaction and the 
further cross-link of SU-8.  
2.3.2.4 Summary of liquid- and vapor- phases silanization effects on the PDMS sur-
face and hard bake effect on the SU-8 surface 
To summarize, the XPS analysis suggests some important characteristics of the PDMS 
surfaces under solution- and vapor- phases silanization, which can assist us towards a good 
bonding method. From the N 1s spectrum result, APTES molecules were brought onto the O2 
plasma activated PDMS surface only under the condition of liquid-phase silanization. The 
alkoxysilane groups from the APTES molecule can potentially react with the –OH group from 
the activated PDMS surface and form Si-O-Si covalent bond. Secondly, before the hard bake at 
a high temperature, the SU-8 surface is less cross-linked and could contain more unreacted 
epoxy resin, which can potentially react with the -NH2 groups from the APTES molecule. Fur-
thermore, the SU-8 surface without a hard bake is more flexible mechanically and can provide 
 
 
Figure 35: The N1s spectra of the PDMS surfaces by XPS under different surface modifications 
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a better surface contact with the PDMS surface. In brief, the liquid-phase silanization method 
is selected as treatment for the PDMS surface, and the difference between with and without 
hard bake SU-8 surfaces will be compared at the following tensile strength test part. 
2.3.3 Manual tensile strength test 
 2.3.3.1 Test sample preparation and manual tensile test set-up 
SU-8 without hard bake can provide a larger number of epoxy groups and better contact 
for adhesion, which can potentially achieve a better bonding quality. To verify the difference 
of SU-8 with and without hard bake in our bonding method, we performed a manual tensile 
strength test on the assembled PDMS and SU-8 samples obtained by combining PDMS samples 
resulting from liquid-silanization of APTES and SU-8 samples with and without hard bake. The 
samples submitted to the tensile test were prepared by bonding a 1 cm in diameter PDMS de-
vice to a 5 μm thick layer of SU-8 deposited on glass (Figure 36). The contact surface between 
PDMS and SU-8 is 0.785 cm2 in circular shape. The surface of the PDMS device was activated 
by O2 plasma and processed with liquid-phase APTES surface silanization. SU-8 samples with 
and without hard bake were both individually bonded with the modified PDMS device and 
tested in this tensile strength test. 
 2.3.3.2 Building of manual tensile test set-up and the theory of manual test 
The testing set-up (Figure 37 A) was built manually. As shown in Figure 37 A, a scale 
carrying a piece of metal of 3.530 kg was attached to a transparent plastic holder with a 
square hole on its top to maintain the tested the PDMS sample part. A lifting-jack was inserted 
into the glass part of the tested sample moved in the vertical direction and can lift up to 6 kg. 
With this set-up, by lifting up the SU-8 coated glass part of the sample, we created a separating 
force between the SU-8 and the PDMS that was attached to the metal plate. This force was de-
cided by the change of mass indicated by the scale. 
 2.3.3.3 Summary of the manual tensile strength test 
With this tensile strength test, we observed the difference in bonding strength between 
the SU-8 with and without hard bake. The samples with hard baked SU-8 broke at the inter-
face of PDMS and SU-8 during the lifting by the lifting-jack. However, the samples where SU-8 
was placed in contact with PDMS without hard bake showed a good adhesion until the separa-
tion process applied reached 440 kPa, which is the highest value the test set-up can provide, 
without failure. This is substantially higher than the working pressure for typical microfluidic 
devices. This manual tensile test revealed that SU-8 is required without a hard bake before 
contacting with the silanized PDMS surface. After the two surfaces were in contact and pro-
cessed by the final baking step (150 °C for 1 h), a strong irreversible bonding that can reach 
440 kPa was made between the PDMS and SU-8. This manual tensile strength test setup is 
flexible and convenient for quick tensile testing in the lab as a preliminary result. 
2.3.4 Ultimate tensile strength test for the bonding 
2. Microfluidic, MEA and integrated microfluidic-MEA devices fabrication 
47 
 2.3.4.1 Set-up and testing sample preparation 
From the manual tensile strength test shown above using the tensile setup made in the lab, 
the bonding with combination of liquid-phase silanized PDMS and SU-8 without hard bake 
reached the 440.6 kPa separation limit without any sign of breaking. To investigate the limit 
of the tensile strength for our bonding method by using liquid-phase silanized PDMS surface 
and the SU-8 surface without hard bake. A tensile test machine from Walter + Bai AG (Lö-
hningen, Switzerland) was used and the test was conducted under force control until the 
breaking point of the bonding. The tested sample was attached between two metal sample 
holders (Figure 38). The separating force on the tested sample was increased by the machine 
until the PDMS and SU-8 bonding interface broke. 
 2.3.4.2 Ultimate tensile strength test result and analysis 
The tensile strength force measured during the tensile strength test was 116 ± 5 N, with 
most of the deformation occurring on the PDMS. This result corresponds to a stress of around 
1.5 MPa at the point where the breaking occured. This is reasonable when we consider the 
tensile strength of PDMS that is much higher than this bonding breaking point. [73]. The pub-
lished result of tensile strength for PDMS and SU-8 bonding reach around 1 MPa [159]. Com-
pared to this value, our method provided a slightly higher strength of the irreversible bond-
ing. 
 
 
 
                                                            A                                                                                        B 
Figure 36: PDMS and SU-8 bonding strength testing sample. (A) PDMS and SU-8 samples for the bonding 
strength test. (B) Schematic of the testing sample. The lower part is a piece of 1mm thick glass coated with a 5 
μm thick SU-8. The upper part is a piece of PDMS obtained by molding 
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                                                                               A                                                                                                      B 
Figure 37: The set-up for the manual tensile strength test.  It includes a scale, a piece of metal mass with a 
plastic PDMS chip fixer on top and a lifting-arm (Fig. A). Detail of the manual tensile test set-up during test 
and its side view (Fig. B) 
 
                                                                       A                                                                      B 
Figure 38: Tensile strength test for the bonding.  (A) Test sample was fixed between the two metal parts 
from the tensile test machine for the bonding strength limit test. (B) A sample during the test 
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2.4 Microfluidic-MEA device 
2.4.1 Surface silanization of the PDMS part from the device 
For the compartmentalized PDMS device fabrication, the PDMS base and the curing 
agent were mixed at a ratio of 10:1. The mixture was poured onto a silicon wafer with struc-
tured patterns, degassed in a desiccator for 20 min until the air bubbles were gone, and cured 
in an oven at 80 °C for 1 h to solidify the PDMS mixture and replicate the pattern on the sur-
face of the PDMS device. Subsequently, a PDMS puncher was used to perforate the PDMS de-
vice to create reservoirs, which connect the microchannels to the macro world for the injec-
tion of fluids into the device. The PDMS surface was first cleaned using adhesive tape to re-
move small particles generated from the hole-punching step. It was then sonicated in an ultra-
sonic bath for 5 min and the surface was dried. The PDMS device was placed in the O2 plasma 
machine to activate the surface (50 W, 0.6 mbar for 30 s). This surface modification step cre-
ates -SiOH groups on the PDMS surface. Afterwards, the PDMS device was immediately im-
mersed into the 99% APTES solution for 5 min and then washed with DI water and dried. The 
CH3CH2O- groups from APTES molecule can attach and react with the -SiOH group from the 
activated PDMS surface and form a covalent Si-O-Si bond [40]. 
2.4.2 Fabrication of the SU-8 part from the device 
For the MEA part in this microfluidic-MEA device, the SU-8 epoxy photoresist was coat-
ed on top of the electrode wires, as it acts as an insulation layer between the cell layer and the 
electrode array layer. Polymer coatings, such as SU-8, are widely used on metals for insulation 
and protection for circuit boards and wires in electronic devices to provide high electrical in-
sulation and protection from environmental damage [22]. This SU-8 insulation layer is essen-
tial for this neural activity recording device because it can also reduce the parasitic capaci-
tance between the electrode wires and the culture medium (conductive saline solution) for 
better signal recording [23]. A 5 μm thick layer of SU-8 was first spin-coated on the MEA sur-
face, and baked by a hot plate at 60 °C for 15 min and another 15 min at 95 °C for a soft bake. 
Then it was exposed to UV light and polymerized by a hot plate at 80 °C for 20 min for a post-
exposure bake, and developed in PGMEA solvent. The SU-8 surface (without the hard bake 
process) from the MEA device also needs to be cleaned using isopropyl alcohol to remove the 
residual particles on the surface. Subsequently, the SU-8 surface was carefully rinsed by DI 
water and dried. 
2.4.3 PDMS and SU-8 bonding for the microfluidic-MEA device 
When the surface modification of the PDMS device has finished, the PDMS device was 
taken out of the APTES solution, washed by DI water and dried. Then the PDMS device was 
immediately aligned onto the MEA device under a microscope without touching the silanized 
surface before alignment was achieved. Afterwards, the microfluidic-MEA device was placed 
on a flat surface inside an oven and a pressure of 2 N/cm2 was applied on the top of the device 
to generate a force between the PDMS and MEA parts to keep these two surfaces fully in con-
tact. The temperature of the oven was slowly increased with a ramp of 2 °C per min to 150 °C 
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and kept at 150 °C for 1 h. Then, the temperature was decreased back to 30 °C naturally. The 
reason for increasing and decreasing the temperature slowly is to avoid structural defor-
mations, as well as the generation of cracks inside the SU-8 material, which would create 
leakage. During this bake time, a chemical reaction occurs between the -NH2 group from the 
APTES molecule on the PDMS surface and the epoxy group from the SU-8 surface [24]. The 
bonding for this integrated microfluidic-MEA device was completed. 
2.4.4 Device preparation for neuronal culture 
The device needed to be sterilized before its use for cell culture. 70 % ethanol was in-
jected into the reservoirs using a syringe, which generated a flow inside the device to both 
wash away the particles remaining inside the chambers and junction channels and sterilize 
them. It was kept inside the device for 20 min, and then sucked out by a vacuum aspirator. 
The ethanol was then replaced with DI water. The chambers and junction channels were 
washed with DI water three times and emptied by using the vacuum aspirator each time. The 
device was then placed in a sterile petri dish (100 mm diameter) and exposed under UV light 
for 1 h. Like normal neural culture in well plates, the cell adhesion surface inside the device 
needs to be treated with a coating solution for faster neuronal adhesion and more homoge-
nous cell distribution. The coating solution, 0.05 % (v/v) polyethyleneimine (PEI), was inject-
ed into the device from the reservoirs and kept in the the chambers and junction channels for 
2 h at 37 °C inside a sterile closed petri dish. Then, the PEI coating solution was removed and 
the device was washed three times with DI water and replaced with Laminin (20 μg/ml) coat-
ing solution and kept at 37 °C for another 20 min. Finally, the Laminin coating solution was 
removed, and the device was washed three times with DI water, and replaced with neural cul-
ture medium (neurobasal, 1 % GlutaMAX, 2 % B27, 1 % penicillin/streptomycin) and kept 
inside a petri dish in the incubator (37 °C, 95% air, 5 % CO2 and 65 % relative humidity), get-
ting ready for the cell placing. 
Primary cortical neurons were extracted from E17 embryos on the day of cell placing. 
The cell suspension was concentrated to 10 million cortical neurons per ml of neural culture 
medium. The prepared microfluidic-MEA device was first emptied, and then filled with the 
freshly prepared cell suspension into the lateral chambers (Region 1 and 3) in the PDMS, care-
fully avoiding air bubbles. The middle chamber (Region 2) which contains no cells was filled 
with the normal neural culture medium. The device and the freshly placed cortical neurons 
were kept inside the incubator for long-term cell grow and neural network development. 
2.4.5 Morphological and electrophysiological observations from the mi-
crofluidic-MEA device 
After 23 days of continuous culture in vitro, spike activities from the neural network 
were recorded with a MEA 1060 System (Multi Channel Systems, Germany) with 60 recording 
channels at 10 or 20 kHz sampling frequency and 10 to 3000 Hz hardware bandpass filter. 
Data acquisition and analysis were obtained using the MC_Rack software (Multi Channel Sys-
tems, Germany). The activity signals from the neuron soma and the axons were recorded indi-
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vidually by the 60 electrodes (Figure 39). The healthy neural network confirms that this 
bonding method is compatible for cell culture since the chemicals introduced by the PDMS 
and SU-8 bonding do not have a big effect on the cell culture. The device did not show any 
leakage or crack under microscope, and the bonding could not be separated afterwards in the 
vast majority of cases (with very rare failures occurring possibly due to the roughness or flat-
ness of the PDMS surface). Concerning the device re-use, the device was aspirated first, then 
washed with DI water and treated with trypsin after use to detach the cells. In the end, the 
device was emptied, dried and kept in a sterile environment until the next use. 
 
Comparing to other technologies such as spin-coating SU-8 onto the PDMS surface, our 
bonding method is simple and convenient as shown in the example of our microfluidic-MEA 
device, and requires only a chemical hood and an oven. The microfluidic PDMS device and 
 
 
    
 
Figure 39: Design of microfluidic-MEA device and recording result.  (A) Schematic of the chambers and junc-
tion channels from the PDMS device and the six columns of electrodes from the MEA device. (B) Picture of the 
interface of PDMS and SU-8 from the device taken by wide field microscope. The functions of each part are 
indicated. Scale: 200 μm. (C) Neural activities recorded by 60 microelectrodes from this microfluidic-MEA 
device. The colors are correlated to the regions with the same colors in Fig. b. Each sub-window corresponds 
to one individual electrode. The signals from the chamber 1 and 3 were recorded from cell soma region, and 
the axon activities were recorded by the electrodes from Chamber 2 
B A 
C 
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MEA device can be fabricated individually and synchronously, and integrated together at the 
end of the process without any limitations. This flexible combination characteristic of this 
bonding method allows an easy fabrication of microfluidic systems and sealed chambers 
based on PDMS and SU-8, while avoiding leakages and allowing the obtained systems to be re-
used after being cleaned. Concerning the device re-use, the device was aspirated first, then 
washed with DI water and treated with trypsin after use to detach the cells. In the end, the 
device was emptied, dried and kept in a sterile environment until the next use. 
 
2.5 Conclusion 
In this chapter, we detailed the fabrication process of microfluidic and MEA devices, and 
especially focusing on our bonding technique of PDMS and SU-8 for the integration of the mi-
crofluidic and MEA devices. This simple and reliable PDMS and SU-8 irreversible bonding 
method, which was based on the covalent bonds, was obtained by introducing aminosilane 
molecules by liquid-phase silanization and SU-8 without hard bake. This bonding method 
was determined by XPS analysis and validated by tensile strength tests. Comparing to other 
technologies such as spin coating, our bonding method is simple and flexible for individual 
devices bonding which means the devices can be fabricated individually and synchronously 
and integrate the devices together at the end of the process without any limitations. This irre-
versible bonding method can furthest avoid leakages and allowing the obtained systems to be 
re-used after being cleaned.  
This PDMS and SU-8 bonding technique solved our issue on the fabrication of our inte-
grated microfluidic-MEA device, which can be used to observe the morphology and electro-
physiology of neural networks in vitro simultaneously. The result from our microfluidic-MEA 
device proved that this bonding method is robust on its quality, flexible for integration, simple 
and user-friendly for manipulation and compatible for in vitro cell culture. This makes it very 
useful for many applications related to PDMS and SU-8 materials, in particular microfluidics 
and lab-on-a-chip device where handling of fluids needs to be performed without leakage. On 
the other hand, this type of integrated devices will give the possibility for neuroscientists to 
study the morphology and electrophysiology of neurodegenerative diseases more thoroughly 
and comprehensively. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“To raise new questions, new possibilities, to regard old problems from a 
new angle, requires creative imagination and marks real advance in sci-
ence.” 
by Albert Einstein 
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3.1 Introduction 
3.1.1 Importance of building a microfluidic-MEA device for studying AD  
In 2011, Anja Kunze used a compartmentalized microfluidic device to build a co-
pathological model and present different phosphorylation states in the axonal network under 
a gradient of OA between the diseased and healthy neuronal populations [85]. This cell mor-
phological study opened the possibility of study cellular and molecular propagation of AD in a 
compartmentalized microfluidic device. However, morphological degradation is not the only 
issue that is happening in an AD brain. The neuropathological, electrophysiological and neu-
roimaging data have suggested that AD exhibits both functional and structural abnormalities 
across anatomically distinct brain regions. This requires innovative tools to extend our re-
search to functional studies for neuronal culture in vitro and to observe electrophysiological 
patterns within the neuronal network. This concept guided us to combine the microfluidic 
device with the MEA device [76, 78, 77, 49]. This combination allows us to observe unique 
features of the electrophysiological properties of the compartmentalized neuronal network, 
such as the depression of neural activity of two distinct neuronal populations during AD prop-
agation [37, 118], the functional neuronal circuitry between specific type of neurons [76, 78, 
49] and some selective pharmacological administrated effects [77]. The microfluidic-MEA de-
vice is designed as a multifunctional tool for neuroscientists to observe the neuronal network 
dysfunctions simultaneously during the propagation of neurodegenerative diseases such as 
AD. Several hypotheses are expected to prove with our microfluidic and microfluidic-MEA de-
vice: 1. the neuron-to-neuron transmission during disease propagation. 2. the function of ax-
onal network during disease propagation. 3. the concentration-dependence drug effect on 
building a diseased model to mimic AD propagation. 4. the order in which the structural and 
functional alterations occur during AD propagation. Based to Anja’s previous work on building 
co-pathological model to study AD, we make several modifications as described in Introduc-
tion Section adapting the requirements for proving our hypotheses. Briefly, it includes the 
longer junction channels to absolute control at the axon region to isolate  axon and exclude 
drug effect on the axon, low and high concentrations of OA exposure for concentration-
dependence drug effect studies, longer observation duration from early stage to the late stage 
during disease propagation and the integration of microfluidic device and MEA recording de-
vice which provide innovative information on the order of occurrence of structural and func-
tional alterations.  
3.1.2 Building a diseased cell model based on Tau pathology 
Microtubule-associated Tau protein (MAPT) is a type of microtubule-associated proteins 
[44] and it mainly works on stabilizing the microtubule function and maintaining the cyto-
skeleton plasticity in neurons [5]. The phosphorylation and the dephosphorylation character-
istics of Tau protein play important roles in maintaining proper axonal connectivity, synaptic 
function as well as neuronal survival [7, 112]. Under AD conditions, the Tau protein is phos-
phorylated at 3 to 4 times increased (6-8 mol phosphate/mol Tau) compared to the healthy 
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situation (1.9 mol phosphate/mol Tau) [80, 11] and the abnormal highly phosphorylation of 
Tau protein leads to hp-Tau which then aggregates into NFTs [87]. NFTs trigger axonal swell-
ings and dystrophic neuritis which is related to axonopathy and neuronal transport deficits 
[46, 5]. In order to build our AD model, the neurons are induced with okadaic acid (OA), which 
is an inhibitor of protein Ser/Thr phosphatases PP1 and PP2A. This effect will further inhibit 
the Tau dephosphorylation, and force the Tau protein to aggregate and become hp-Tau mim-
icking the AD pathpology [74, 75].  
3.1.3 Disease propagation studies by using microfluidic and microfluidic-
MEA devices 
Based on this concept of integrating microfluidic and MEA devices, this integrated micro-
fluidic-MEA device was designed, fabricated and tested. The added MEA device provided an 
electrophysiological observation platform to analyze the functional interactions in the neu-
ronal network. Using these two platforms, a co-pathological model was built to study AD 
propagation between diseased (OA-exposed) and healthy (without OA exposure) neuronal 
populations and test the concentration-dependent effect on the neuronal network. The exper-
iment process is presented in Figure 40. Primary cortical neurons are first loaded in the two 
lateral chambers in the device. Then the culture was maintained for 21 days and the mature 
neural network is built during this time. The neuronal population in the left chamber region 
was induced with OA, while the morphological and electrophysiological alterations were 
tracked during the disease propagation in the whole neuronal network, including cytoskeleton 
alteration, hp-Tau transportation and neuronal activity variation.  
 
3.2 Materials and Methods 
3.2.1 Design and fabrication process of microfluidic and microfluidic-MEA 
devices 
 For building a diseased and healthy neuronal network with axon isolation in between, 
the pattern of our microfluidic device was designed with three regions (Figure 41): Region 1. 
OA-exposed neuronal population; Region 3. Neuronal population without OA exposure (OA-
unexposed); Region 2. Central channel for axon growth. Between each two neighboring re-
gions, there are 50 junction channels for physical separation of axon from the OA-exposed and 
the OA-unexposed neuronal populations (Figure 41 B). The primary neuronal culture was per-
formed in Regions 1 and 3 microchannels with dimension of 1.5 mm in width, 4.5 mm in 
length and 100 μm in height. The axon connection was formed in Region 2 microchannel with 
dimension of 1 mm in width, 4.5 mm in length and 100 μm in height. The junction channels 
are 20 μm in width and 10 μm in height and 500 μm in length, and it serves as physical barri-
ers for neuronal bodies. They stop the soma from entering the junction channel and let the 
neurite to pass through. As described in the introduction chapter, the 500 μm length of junc-
tion channels are able to create an axon-connected region (Region 2) without dendrites 
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Figure 40: Schematic picture of the experiment process.  It includes device (1) (black round spots represent 
electrodes), cell loading (2), neurons growth and network building (3), OA-exposure (4), cells become dis-
eased (5), and further observation (6) 
 
 
Figure 41: Image of the microfluidic-MEA device and its internal structures.  Top view picture of the integrated 
microfluidic-MEA device (A).  It consists of the compartmentalized microfluidic device and the MEA device. (B) 
Image of the interface between the microfluidic and MEA devices. The MEA device has 60 microelectrodes 
with 2 by 10 arrangements in the culture regions, and the junction channels from the microfluidic device. (C) 
Immunofluorescent image of neuronal culture stained with the neuron-specific protein MAP2 (green), axon-
specific neurofilaments (red) 
A B 
C 
3. Propagation of Tau pathology in microfluidic and integrated microfluidic-MEA devices 
57 
growing into the adjacent Region 2 according to previous study [144, 145]. From our result in 
Figure 41 C, the stained axon in Region 2 proves that the axons are very efficiently separated 
from the dendrite. For the microfluidic-MEA device (Figure 41 A), the microfluidic device is 
bonded with the MEA device and the pattern of the electrodes from the MEA device are 
adapted to the design of the three regions (Figure 41 B).  The detailed fabrication processes 
are presented in Section 2.2.1 and 2.2.2. The bonding method of microfluidic and MEA devices 
is detailed in Section 2.4. 
3.2.2 Preparation and plating procedure for the devices 
The microfluidic and microfluidic-MEA devices have the same process for preparation 
and cell plating. However, the microfluidic devices are used for the immunocytochemistry 
staining for morphological studies and the microfluidic-MEA devices are used for electrophys-
iological studies, so that the morphological and the electrophysiological data are not from the 
same culture sample. The device was coated with 0.05 % PEI solution overnight at 4 ? the day 
before plating. On the cell placing day, the devices were coated with laminin (20 μg/mL) for 20 
min at 37 ?. Between each coating step, the device was washed with sterile DI water three 
times to remove any residuals from the surface coating step. Before cell suspension injection, 
the device was washed with fresh neurobasal neuronal culture medium in order to wet the 
surfaces and avoid air bubbles. All the materials used for cell culture were purchased from 
Invitrogen (Carlsbad, CA). 
All the experimental procedures were carried out according to the Swiss federation 
rules for animal experiments. Mouse primary cortical neurons were obtained from embryonic 
day 17 (E17) fetal mouse. Cortices were digested in culture medium added with papain (20 
U/mL) and dissociated by mechanical trituration. The cortical neurons were uniformly dis-
tributed inside the neurobasal medium supplemented with 2 % B27 and 2 × 10-3 M GlutaMAX 
as cell suspension. The cell suspension was loaded into a 1.6 mm diameter PTFE tube that can 
provide sufficient pressure to flow the neurons into the neuronal culture region in a relatively 
homogeneous distribution. There were 4 × 105 cells injected into the microchannel culture 
areas in each device. The devices were kept inside 10 mm petri dishes with an additional wa-
ter container to slow down medium evaporation. All devices were then maintained in normal 
culture condition (37 ?, 5 % CO2) and the medium was refilled repeatedly depending on the 
experiment schedule.  
3.2.3 Induce Tau hyperphosphorylation via OA exposure 
After 21 days in vitro (DIV), these two neuronal populations were mature with neu-
ronal connections built up in the axon-connected region. The drug exposure time point was 
chosen based on previous studies, which show that mature neuronal networks with stable 
spontaneous activity patterns have been observed after 21 DIV [23]. For the disease induced 
cell population, local OA exposures with high and low concentrations (600 nM and 60 nM in-
side neurobasal medium, respectively) were used in Region 1. This drug exposure procedure 
lasted for 75 min that can potentially induce hp-Tau. The drug from Region 1 was then washed 
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away, and replaced by fresh culture medium. In order to observe the propagation from ex-
posed to unexposed neuronal populations, the measurement time points have been set at 0 h 
(immediately after the 75 min of OA exposure), 6 h, 24 h, and 48 h. The 48 hours observation 
after the drug exposure is named as a “recovery period” for the neuronal network.  
Concerning the liquid isolation requirement for OA exposure in this experiment, it is 
critical to keep the drug isolated from all the other unexposed channels to exclude the possi-
bility that the drug has effect on the unexposed cell population by diffusion. To fulfil this goal, 
several aspects were taken into consideration when we designed the device and the experi-
ment manipulation procedure, to ensure the separation of OA exposure. The junction channels 
are long enough to exclude the dendrite from the axon and the cross-section is small enough 
to stop the soma to pass through the junction channel. The channels were washed several 
times by culture medium to clean up the drug that possibly existed in the channels. 
Each two neighbor compartments are not absolutely isolated because they are con-
nected by junction channels. In order to demonstrate there is no drug effect on the un-exposed 
neuronal population during the 75 min drug exposure procedure because of the drug diffusion 
through the junction channels, a control experiment was designed. The neurons were placed 
only in the right lateral channels, not in the both sides, and grew for 21 days. On 21 DIV, the 
drug was injected into the left lateral compartment, kept in the compartment for 75 min and 
was removed afterwards. The cell population in the right side lateral compartment was im-
aged by confocal microscope for cytoskeleton analysis.  
 
3.2.4 Immunocytochemistry staining for morphological studies 
 The samples from the microfluidic devices were used for immunocytochemistry stain-
ing. At each selected time point for observation, the neuronal culture in the microfluidic device 
were fixed with 4 % paraformaldehyde (PFA) in 0.1 M phosphate buffered saline (PBS) buffer 
for 20 min and rinsed with PBS three times after the fixation. The neurons were permeabilized 
with 0.25 % Triton and 1 % BSA for 20 min. Then the fixed sample reacted with the primary 
antibodies overnight at 4 ?, and after that, the solution was removed and washed with PBS 
buffer. The fixed culture was incubated with secondary antibodies in the dark for 2 h at room 
temperature. In the end, the secondary antibody solution was removed and washed with PBS 
buffer, and all the fixed samples were preserved at 4 ? for confocal microscopy imaging. 
In this study, neuronal cytoskeleton, axon and hp-Tau at Ser262 site were visualized. The 
primary antibodies included the rabbit polyclonal antibody which stains for the MAP2 (neu-
ronal marker, 1:150 dilution, Acris antibodies, Germany), rabbit polyclonal antibody which 
stains for the endogenous level of Tau when it is phosphorylated at Serine 262 (Tau Phospho-
Ser262 marker, 1:150 in dilution, Signalway Antibody, Switzerland) and mouse monoclonal 
antibody which stains for the pan-axonal neurofilament (neuronal axon marker, 1:500 in dilu-
tion, COVANCE, USA). The second antibodies were the Alexa488-conjugated antibody for rab-
bit IgG (1:500 in dilution, Dionova, Switzerland) and the Rhodamine-conjugated antibody for 
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mouse IgG (1:200 in dilution, Dionova, Switzerland). DAPI was used as well to visualize the 
nuclear morphology. 
For this experiment with microfluidic device, we used 21 DIV neuronal cultures and the 
experiment was repeated three times with three rounds of neuronal culture respectively. 
There were 60 devices used in total and 20 devices were used for each round. For each round, 
4 samples were fixed before the OA exposure as a control group. There were 8 samples were 
exposed under the high concentration of OA exposure (600 nM). Among the 8 exposed sam-
ples, 2 samples were fixed for each time point, at 0 h, 6 h, 24 h, 48 h, separately. One out of the 
two samples was stained for the cytoskeleton and the other one was stained for the hp-Tau. 
Another 8 devices were exposed under the low concentration of OA exposure (60 nM), fixed at 
the same time points and repetition as the high concentration group.  
3.2.5 Extracellular recording method and parameters settings 
In order to study this compartmentalized neuronal network in a comprehensive way, not 
only structural connectivity was studied, but also the functional connectivity between the two 
neuronal populations has been investigated. In this experiment, the microfluidic-MEA devices 
were used for recording the neuronal activity in the compartmentalized neuronal culture. In 
this recording experiment, the extracellular recording was performed on the 21 DIV, using a 
MEA 1060 recording system (Multichannel Systems, Germany). This MEA 1060 system is 
equipped with 60 recording channels at 10 or 20 kHz sampling frequency with a hardware 
bandpass filter of 10-3000 Hz. Mc_Rack software was used for data recording and the record-
ed data was filtered at 200 Hz (high-pass Butterworth). The analysis of detecting and extract-
ing spikes and bursts was performed with MC_Rack software following the manual provided 
by Multichannel Systems. For recording reliability reasons, the recording was started 10 min 
after the MEA was transferred out from the incubator, in order to avoid the effects of mechani-
cal perturbation and environmental transit [153]. Because the environment of the recording 
room was not under controlled temperature and CO2 the recording duration for each device 
was fixed 10 min to avoid prolonged exposure outside an ambient environment. When the 
recording was done, the sample was transferred back to the incubator until the next experi-
mental time point for recording. After spike sorting, the spikes were stored as series of time 
stamps for further functional connectivity analysis. There are two quantitative parameters 
that are defined for analyzing the extracellular recording data: the spike number that corre-
sponds to the total number of spike during the 10 min of recording, and the burst number that 
corresponds to the total number of burst events occurred over the 10 min of recording.  
The neuronal activity recording experiment with the microfluidic-MEA device was re-
peated 5 times with 5 rounds of cortical neuronal culture respectively from 21 DIV culture. For 
each round of experiment, one sample was induced under high concentration of OA (600 nM), 
another sample was treated under low concentration of OA (60 nM) and one sample as a con-
trol. 
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3.2.6 Recording data analysis and statistical analysis 
The neuronal activity data was stored in a digital format for spike sorting. Data were 
analyzed offline using MATLAB  (The MathWorks Inc., USA) based on  a  typical spike sorting 
algorithm to estimate the signal-to-noise ratio (SNR) [152]. Sensing noise, instrumentation 
interference, and small amplitude signals from neighboring neurons were considered as back-
ground noise. The spikes from a single electrode were not discriminated and sorted for signals 
from different neurons, so the individual spike train may contain spikes from one or more 
neurons [76]. All the statistical data were presented in the way of mean ± standard deviation 
(SD). The spikes number ratio and bursts per minute ratio were subjected to two-way analysis 
of variance (ANOVA) for multiple comparisons. A p value of less than 0.05 was considered for 
the statistical significance. 
 
3.3 Results 
3.3.1 Control experiment 
Following the experimental design of the control experiment demonstrated in Section 
3.2.3, the control experiment was done, and the result is shown in Figure 42. From the cyto-
skeleton alteration result in Figure 42 B, no severe cell damage was observed from the mor-
phological result, and in Figure 42 C, no severe decline of neural activity was observed. From 
this result of control experiment, we can exclude the severe effect on the un-exposed cell pop-
ulation from the drug diffusion during the 75 min drug exposure. In the main experiment, the 
severe morphological and electrophysiological alterations both should be due to the effect 
from the connected drug-exposed cell population. 
3.3.2 Cytoskeleton alterations after OA exposure  
 One of the main observations that have been observed during AD progression is the 
loss of microtubule integrity related to neurodegeneration [68, 69].  In our experimental mod-
el, the OA-mediated cytoskeleton destabilization was generated and the cytoskeleton integrity 
with neuron specific MAP2 protein was visualized. This diseased cell model was physically 
connected to another no drug exposed cell population through axon network. In this way, it is 
possible to observe the disease propagation from diseased to healthy neuronal population 
mimicking the disease progression in natural tissue.  
Under high concentration of OA exposure (600 nM), as shown in Figure 43 A, the neu-
ronal cytoskeleton of the diseased neuronal population degenerated continuously with time 
and lost its connection network eventually. Similar phenomenon was observed as well in the 
unexposed side with a delay compared to the exposed neuronal population. About this origi-
nal healthy cell population, it eventually revealed degradation until 48 h. This is due to the 
effect from the OA-induced cell population, and the disease propagated and caused serious 
damage on the unexposed population. Under the low concentration OA exposure (60 nM), the 
OA-exposed neuronal population showed higher neurite survival compared to the high con-
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centration group. However, a severe neurite loss was observed after 48 h, shown in the Figure 
43 B. About the unexposed side, significant neuritic degeneration (compared to the result 
from high concentration of OA exposure) was not observed until a slight neurite loss was de-
tected at 48 h.  
From those results above, we observed the disease was progressing from the OA-induced 
diseased neuronal population to the healthy neuronal population through the connected ax-
ons. Under high concentration of OA exposure, the neurons exhibited more severe damage to 
the exposed and unexposed cell populations compared to the low concentration condition. 
Additionally, more rapid and aggressive progressing pattern was revealed from the unexposed 
side as well. All these evidences indicate that this drug exposure by OA for building a diseased 
model is concentration dependent, and different propagation patterns were noticed.  
 
Figure 42: Control experiment for drug diffusion effect test.  (A) Schematic of the control experiment design. (B) 
Cytoskeleton alteration on the cell population in the right lateral compartment. Staining: MAP2, green. (C) 
Neural activity result on the cell population in the right lateral compartment 
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A 
B 
Figure 43: Cytoskeleton alteration visualized by MAP2 immunocytochemistry staining as green color.  (A) 
After high concentration of OA exposure (600 nM). (B) After low concentration of OA exposure (60 nM). 
Images from Region 1 and 3 were captured from the same device to avoid biological variation. Scale: 100 
μm 
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3.3.3 Propagation of Tau hyperphosphorylation between diseased and 
healthy neural populations by axonal connection 
Following the fact that the disease propagated between two cell populations through the 
axonal connections based on the features of cytoskeleton alteration presented above, the next 
step, the hp-Tau transportation during disease progression and the sequence of its appear-
ance in the neuronal network were investigated. Benefitting from the compartmentalized 
structure of the microfluidic device, the isolated unobstructed axonal network will permit us 
to possess a better comprehension on the role of axon during disease propagation.  
The experimental procedure on the exposed cell population was as same as the experi-
ment about cytoskeleton alteration presented before: exposed cell population was under OA 
exposure for 75 min, either at high concentration of OA (600 nM) or at low concentration of 
OA (60 nM). The samples were fixed at different time points (0 h, 6 h, 24 h and 48 h). For the 
hp-Tau tracking, the phosphorylation site Tau Ser-262 (pSer262) was marked and tracked as 
an AD relevant site, which is often found in AD brain [154]. The imaging for Tau Ser-262 stain-
ing from the Region 1, 2 and 3 inside the microfluidic device was done with confocal micro-
scope. From the high concentration of OA exposure (600 nM) results in Figure 44, it was firstly 
observed that immediately after 75 min OA exposure, a significant amount of hp-Tau was dis-
tributed in the axon region (Region 2) from diseased towards the OA-unexposed neuronal 
populations with a gradient pattern. Six hours later, hp-Tau in the axon region suddenly dimin-
ished dramatically, possibly dissipated into the culture medium and became residues near the 
entrance of junction channels. Due to the continuously dissipation, less amount of hp-Tau was 
observed in the axon region at 24 h and 48 h time points. About the OA-exposed region, uni-
form hp-Tau protein aggregates were formed directly after the drug exposure, with a signifi-
cant lower intensity compared to the axon region. Six hours after, hp-Tau aggregated seriously 
around the neuronal body and in their neurites. More severe hp-Tau aggregates were revealed 
at 24 h and dissipated into the cell medium between 24 h and 48 h. This phenomenon consists 
with the observation from the cytoskeleton alteration result at 24 h that the neuronal struc-
ture was dramatically damaged (Figure 43). At the unexposed region (Region 3), no hp-Tau 
protein aggregation was noticed in the unexposed population immediately after the drug ex-
posure. Until 6 hours later, hp-Tau started to aggregate slightly around the neuronal bodies 
and accumulated in the neurites. More significant hp-Tau aggregation inside neuronal soma 
appeared at 48 h of recovery. 
Based on the result above on the hp-Tau propagation under high concentration OA expo-
sure, the result was compared with the condition of under low concentration of OA exposure 
(60 nM) in Figure 45. A similar phenomenon was shown that the hp-Tau was firstly accumu-
lated severely at the axon region, instead of the OA-exposed cell population region. However, 
under low concentration of OA exposure, the speed of hp-Tau aggregation was slower because 
of the observed delayed of hp-Tau accumulation in the axon region during the first 6 hours. 
The propagation pattern was less aggressive depending on the intensity of the accumulated 
hp-Tau in the cell bodies and neurites from both of the exposed and unexposed cell population 
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regions. There was no distinct hp-Tau aggregation found in the unexposed cell population at 
48 h under low concentration of OA exposure while the neurons still had their cytoskeleton 
with a slight damage (Figure 45 B 48 h). 
3.3.4 Spontaneous firing rate and burst rate during the disease propaga-
tion 
 Spontaneous spike activities recorded from the cortical neuronal network in vitro were 
considered as a functional indicator for network behavior [103]. With our integrated microflu-
idic-MEA device, neuronal activities were recorded from the compartmentalized neuronal 
network. The results about the spike number variation during disease propagation under high 
(600 nM) and low (60 nM) concentrations of OA exposure were shown in Fig. 4-6. The spike 
rate was normalized to the control sample before OA exposure (by definition of 100%). The 
average values and standard deviations were obtained from five independent cultures.   
Under high concentration of OA exposure (600 nM), the spike activities from the exposed 
neuronal population was significantly inhibited immediately after the OA exposure and re-
mained low at the following 6 h, 24 h and 48 h recording time points. The axon presented a 
similar neuronal activity decreasing pattern with a slightly delay at the beginning compared to 
the OA-exposed cell population (Fig. 4-7). Different phenomenon has been shown at the unex-
posed cell population. The spike number gradually increased with time until 6 h and then 
started to decrease, like a pattern of temporary excitement. This pattern was also observed in 
the low concentration of OA exposure situation, but in all the three regions. Decreased spiking 
activity was first observed in all regions. However, after 24 hours recovery, the excitement pat-
tern started and the activities were increased in all three regions with different ranges. The 
neuronal activity changing ranges under low concentration exposure were all in a lower level 
compared to the high concentration exposure.  
 Besides the spike number, the burst was also analyzed as another characteristic to il-
lustrate the activity of the neuronal network. The bursts are defined as repeated spikes occur-
ring during a short time interval and they are supposed to be synchronized with the spiking 
activity. The functional importance of generating bursts is to increase the reliability of com-
munication between neurons and to avoid synaptic transmission failure. Compared to spike, 
burst might afford more precise information and effective mechanisms for selective communi-
cation between neurons and produce long-term synaptic plasticity and information pro-
cessing [22]. In our experiment, the bursts number was normalized to the burst number from 
the control sample before OA exposure (by definition of 100%). The result about the spike 
number alteration during disease propagation under high (600 nM) and low (60 nM) concen-
trations of OA exposure is shown in Fig. 4-6. The average values and standard deviations were 
obtained from five independent cultures. Under high and low concentration of OA exposure 
(600 nM and 60 nM), the inhibited and excitement patterns are very similar to the spike num-
ber result respectively.  
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3.4 Discussion 
3.4.1 Structural characteristics alterations during disease propagation 
Benefitting from this disease propagation model built in the microfluidic device, the 
structural alterations on the neuronal cytoskeleton were identified in the diseased and healthy 
cell populations and their axonal network. It provides us the evidence of the disease propaga-
tion from the diseased neuronal population to the healthy neuronal population through the 
neuronal connection. High (600 nM) and low (60 nM) concentrations of OA were used to in-
duce AD. From both situations, the hp-Tau was first accumulated in the axon part. Hp-Tau was 
then rapidly accumulated at the OA-exposed cell population. As disease propagated, the hp-
Tau then became punctuated spots in the axon part and axonal degeneration happened. This 
observation is consisted with the assumption of Tau toxicity for AD disease from [68] indicat-
ing that the hp-Tau should first be accumulated in the axon and then spread into the cell soma. 
This is due to the main function of Tau protein is to stabilize the microtubules and regulate the 
motor-driven axonal transport [48]. During the disease propagation, the aggregated hp-Tau 
started to be dissipated into the medium. The neurons also started to have cytoskeletal dam-
age and lost their structure in the end.  
 
Figure 44: Disease propagation patterns during recovery period (0 h, 6 h, 24 h, 48 h) under high concentration 
of OA exposure (600 nM).  Hp-Tau was visualized by pSer262 immunocytochemistry staining (green). Images 
from Region 1, 2 and 3 at each time point were captured from the same device. Scale in Region 1 and 3, 50 μm. 
Scale in Region 2, 100 μm 
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 Comparing this result of hp-Tau propagation in Figure 44 and Figure 45 with the cyto-
skeleton alteration in Figure 43, under high concentration of OA exposure, the cytoskeleton 
was gradually damaged on both the exposed cell populations while the hp-Tau was accumu-
lated in the OA-exposed cell population. This had an effect on the OA-unexposed cell popula-
tion as well on the level of hp-Tau and the cytoskeleton. Under low concentration of OA expo-
sure, the OA-exposed population showed increasing intensity of hp-Tau and damage on the 
cytoskeleton, however, the OA-unexposed cell population did not show increasing accumula-
tion of hp-Tau and severe damage on the cytoskeleton. This proves that different concentra-
tions of drug exposure caused different effects on the unexposed cell population and present-
ed different patterns of disease propagation. 
3.4.2 Different functional patterns under different concentrations of OA 
exposure 
The integration of compartmentalized microfluidic device and the MEA device provides 
additional electrophysiological characterization of the neuronal network compare to a normal 
MEA device without compartmentalized pattern. With this device, the recorded spontaneous 
  
 
Figure 45: Disease propagation patterns during recovery period (0 h, 6 h, 24 h, 48 h) under low concentration of 
OA exposure (60 nM).  Hp-Tau was visualized as green color by pSer262 immunocytochemistry staining. Images 
from Region 1, 2 and 3 were captured from the same device. Scales are as same as in Figure 44 
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activity data was characterized by the spike rate (Figure 46) and burst rate (Figure 47). Dur-
ing the observation of disease propagation, two distinct electrophysiological patterns were 
observed: depression and temporary-excitement electrophysiological patterns. Depression 
pattern was only observed under the high concentration of OA exposure (600 nM), from the 
OA exposed neuronal population and the axonal network recording result. Significant de-
crease on the spike rate (Figure 46 A) was observed and the burst activity (Figure 47 A) im-
mediately after the high concentration exposure and without obvious sign of excitement. Un-
like the significant rapid decline of the neural activity under high concentration drug expo-
sure, different patterns of temporary-excitement were observed under low concentration of 
OA exposure (60 nM). The OA exposed neuronal population had reduced around half spiking 
rate immediately at 0 h (Figure 46 B), with slight disturbance on the burst activity at the be-
ginning (Figure 47 B). With time progressing, dramatically increasing of spike numbers was 
observed during the first 24 h recovery and then an obvious decrease happened at 48 h, it is 
named “temporary-excitement pattern” by us. Similar activity pattern was also observed on 
the OA-unexposed neuronal population in both concentration conditions, which is under the 
effect from the OA-exposed neuronal population through the axonal connection. This might be 
related to the functional adaption of neuronal network exposed from pathological challenge. 
Similar phenomenon was observed and published in the previous studies on the AD-related 
animal [28, 27, 128], where the neurons from cortical slices of transgenic mice (rTg4510) dis-
played more excitable behavior after surviving a Tau-induced degenerative disease. From the 
different patterns above, it was speculated that both the low concentration exposure and indi-
rect drug exposure effect potentiated the synaptic transmission and caused the "temporary-
excitement electrophysiological pattern" observed and named, whereas the direct high con-
centration exposure caused the synaptic depression that we called "depression electrophysio-
logical pattern". These findings verify the previous similar studies focusing on the electrophys-
iological effect of Aβ with varied concentrations [131] or different types of Aβ species mix-
tures [86]. 
 
Figure 46: Spike rate acquired by extracellular recording under two concentration of OA 
treatment (600 nM, 60 nM) which represented the functional patterns during the disease 
propagation. 
Figure 47: Burst rate acquired by extracellular recording during two concentration of OA 
treatment (600 nM, 60 nM) which represented the network synchronous pattern changed 
during disease propagation 
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3.4.3 Order of occurrence of structural and functional alterations during 
disease propagation  
Both of our morphological and electrophysiological results confirmed that pathological 
event was happening during the disease propagation in the neuronal culture from the devices. 
However, as far as we know, the order in which the structural and functional alterations occur 
during AD propagation is still not clear. Benefit from microtechnology, we attempted to fill this 
gap with our microfluidic device for morphological studies and integrated microfluidic-MEA 
device for electrophysiological studies. Morphological and electrophysiological data are 
brought together for a more comprehensive analysis. About functional observation on the 
spike and burst rate, it was observed a 6 h delay of immediate decrease in the burst rate 
(Figure 47) compare to the spike rate (Figure 46 B) after the OA exposure at low concentra-
tion exposure, and both followed with the temporary-excitement pattern activity changes. Af-
ter comparing the time points of morphological and electrophysiological changes with the OA-
exposed neuronal population, the recorded functional changes (declined spike rate) happened 
much earlier before the observed structural changes (increased hp-Tau accumulation) under 
the effect from the OA-induced neurotoxicity. For instance, about the unexposed cell popula-
tion under low concentration of exposure, there was no ph-Tau aggregation existed at 48 h 
and the cytoskeleton was only with slight damage. But from the neuronal activity data record-
ed from MEA device, the neurons were still already at an inhibited mode based on the decreas-
ing on the spike rate and burst rate. All this results coincide with the previous studies about 
the functional electrophysiological changes occur prior to the substantial deposition of NFTs 
and neuron loss [27] and also the results from the brain imaging technique lately published 
[4] which indicates that the functional changes/cognitive declines in the AD patients’ brains 
are altered prior to the structural changes/disconnection in AD as well. In this situation, ap-
plying biomarkers of neuronal function is able to detect AD even before the structural brain 
changes happened [39]. This will bring predictive value in early diagnosis for AD which is an-
other issue so far. 
 
3.5 Conclusions and future prospects 
In this study, compartmentalized microfluidic device and an integrated microfluidic-MEA 
device were used to simulate the propagation of neurodegenerative disease with functional 
and structural observations synchronously. A co-pathological model was built by diseased and 
healthy neuronal populations co-culture, and the results showed that the Tau pathology seems 
to propagate along the two distinct neuronal populations through the axon region. From the 
structural aspect, specific propagation pattern appeared as following sequences: hp-Tau ag-
gregation was appeared in the OA-exposed neuronal population and distributed along the ax-
ons. With time progressing, the OA-unexposed neuronal population began to accumulate hp-
Tau inside the neuronal soma. Those results proved that the hp-Tau generated from diseased 
neurons could propagate through axon and cause pathological damage to the cytoskeleton of 
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healthy neuronal population. This is consisted with our hypotheses on the neuron-to-neuron 
transmission and proved the importance of axonal network during disease propagation. From 
the functional aspect, two different functional activity patterns were observed during the dis-
ease propagation under two different concentrations of OA exposure, depression and tempo-
rary-excitement electrophysiological patterns. The hyperactive property of neuronal network 
is probably related to the regulation of functional networks [28]. What is more, it was proved 
that the functional changes occur prior to the visible structural changes as well. This brings us 
more knowledge that can potentially helpful for AD early detection studies. Under different 
concentrations of OA, both of the morphological and electrophysiological alterations showed 
different propagation patterns during AD propagation and this is consisted with our hypothe-
sis on the concentration-dependence on drug effect. This indicates that the different concen-
trations of drug used to induce disease cell model should be considered to cause different ef-
fects on morphology and electrophysiology when we build a diseased model in vitro for neu-
rodegenerative disease studies. Above all, all these morphological and electrophysiological 
evidences obtained from the microfluidic device and microfluidic-MEA device prove that these 
devices are promising tools for neuroscientists to understand neurodegenerative diseases. 
The quantitative data obtained from the spontaneous spike activities provided us the status of 
the neurons. However, for the future study, it is consequential to penetrate deeper to explore 
how the different neuronal populations communicated. With this microfluidic-MEA device, the 
functional connectivity maps can be derived by cross-correlation analysis to understand the 
dynamic and spontaneous neuronal network at different stages of development during dis-
ease propagation. In addition, as there are two major hallmarks of AD including NFTs and Aβ 
plaques, for our future research on the pathological mechanisms for AD, Tau protein is not the 
only factor that we should consider. It is necessary to extend our focus on the link between Aβ 
and hp-Tau toxicity and this could play a fundamental role in developing potential targeted 
therapies. 
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4.1 Introduction 
Previous presented studies on AD in this thesis are all based on 2D neuronal culture. 
However, the neuron, as the most basic element in our nervous system, is very sensitive to the 
surrounding cultural environment [121]. 2D cell culture is limited to the low cell density and 
the integrated neural network comparing to the 3D cell culture. There is not only difference 
on morphological aspect, but also the electrophysiological recording in vitro showing different 
spike patterns between 2D and 3D environments [25, 162]. Many 3D neuron cell cultures 
have been established until now. The most commonly used method is by using hydrogel as a 
scaffold to make homogenous 3D cell culture [92]. In this chapter, two different types of beads 
are presented to build 3D neuronal culture, including silica beads and agarose-alginate beads. 
Beads are microspheres that can provide flexibility as carriers. For example, they were used 
as solid-phase carriers for chemical reactions within sealed micromachined device and to cap-
ture target analytes such as proteins and nucleic acids [149]. In this experiment, the beads are 
used as neuron carriers and they bring the neurons into the microfluidic device with layer 
pattern to create an artificial multi-layer 3D neural cell culture platform. This typical cortical 
cell layer-pattern model will assist us to study neuron-to-neuron interactions in 3D environ-
ment, and will potentially help to overcome the disadvantages of 2D culture for AD studies 
such as the Aβ plaques formation. 
 
4.2 Methods 
4.2.1 Design of layer pattern in microfluidic device 
First, we first injected silica beads from different inlets trying to load the beads into the 
device. The preliminary test showed that it would help to put the device at a sufficiently large 
angle as an inclined device to let the beads flow through the channels by gravity and add 
slightly vibration to make the beads flow. We observed that firstly most of the beads were 
accumulated at the bottom of the injection reservoir (Figure 48 A). A pump system was added 
to create a slight flow in the channel. Furthermore, it was impossible to arrange the silica 
beads into well-organized layers by loading from different channels. All the silica beads ended 
up being mixed in a random order (Figure 48 B). This indicated that using one main channel is 
not enough to pattern the beads, it was also necessary to add physical barriers in the main 
channel to maintain the layer structure and a layer-pattern was designed for the microfluidic 
device. Three rows of pillars were added into the main channel to guide the beads to flow and 
be patterned in four layers (Figure 49). Some PDMS pillars were set at the end of the main 
channel to block the beads.  
Different designs had been proposed based on bead size and the fabrication constraints. 
After some tests, we decided to add rows of pillars (diameter in 40 μm) into the main channel 
to separate the silica beads. The distance between the centres of two pillars is 70 μm, with the 
edge-to-edge distance being 30 μm. Therefore, the beads (diameter in 45 μm) will not be able 
to move to the other layers. The end of each channel is defined by thicker pillars (diameter in  
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50 μm), which constrain the beads to stay within the channel (Figure 49 B). The fabrication of 
the microfluidic device was followed with the method illustrated in Section 2.2.1. 
 
                                                                 A                                                                                                    B    
Figure 48: Preliminary results from loading beads into the microfluidic device without pillars pattern in the 
middle channels.  (A) Micro-beads accumulated and blocked at the bottom of the injection reservoir. (B) Micro-
beads randomly patterned in the PDMS chip. (Scale: 100 μm). Images were taken by wide field microscope 
 
                                                                           A                                                                               B    
Figure 49: Four-layer pattern design of microfluidic device.  (A) Mask design in Clewin for the microfluidic 
device. (B) Four layers pattern with three rows of pillars and the pillars at the bottom to block the beads and 
keep them in the channels 
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4.2.2 Experimental set-up 
To load cells into the channels of the microfluidic device, sometimes micro-syringes and 
pumps can be used. Especially, for example, different contents can be brought into the micro-
fluidic system from different channels and then generate a special layer-pattern through the 
laminar flow regime [83]. Controlling the flow rate during cell loading through micro-syringes 
and pumps allows us to automate this process. In this experiment, the beads loading setup is 
shown in Figure 50. This micro-syringe setup was used to load beads and perfuse cell culture 
medium to refresh the medium. 
 
 
 
4.3 3D Silica beads culture in microfluidic device 
4.3.1. SHSY-5Y cell line culture on silica beads 
The 45 μm silica beads were chosen for our experiment, because the axons can bridge to 
neighbour beads quicker compare to bigger sizes beads. At the same time, there is no obvious 
difference on the rate of growth between different sizes of beads [125]. The silica beads were 
ordered from MO-SCI Specialty Products.  
When the microfluidic devices were fabricated, the first question was the technique of 
culturing cells on the beads surface at a good cell density. The SHSY-5Y cell line was chosen to 
 
                                                                         A                                                                                                           B 
Figure 50: The cell seeding setups for cell culture in a microfluidic device in a sterile environment.  The setup 
consisted of a flow controlling syringe pump, a digital microscope and a heating system. (A) A syringe was at-
tached on the top of a syringe pump and should be connected to a reservoir from the PDMS device. PDMS device 
was fixed by scotch tape on a holder. A digital microscope, which was connected to a laptop, was placed under the 
device. Medium was always kept in the heater. (B) Detailed image showing the PDMS microfluidic device and the 
digital microscope 
 
4. 3D beads-based neuronal culture in microfluidic device 
77 
run the test. First, the beads needed to be sterilized. 70 % ethanol was used to sterilize the 
beads overnight on the roller to have a better sterilization. On the second day, we dried the 
beads in centrifuge machine at 17000 g for 3 min and then incubate the beads in borate buffer 
solution for 1 h. Then we dried the beads again in centrifuge machine at 17000 g for 3 min. 
For the coating of the beads surface like surface coating in a normal cell culture dish, PLL coat-
ing solution was added into the eppendorf to coat the beads overnight on the roller to make 
sure all the beads were coated with PLL. In the end, the beads were washed with phosphate-
buffered saline (PBS) buffer and dried again in centrifuge machine at 17000 g for 3 min for the 
experiment. For cell seeding, 200 μl tip was dipped into the prepare beads sample twice to 
transfer the prepared beads into the 24 well plate. Then 450 μl of cell culture medium was 
added into the 24 well plate. The culture medium for the SHSY-5Y cell line was 1 % penicil-
lin/streptomycin (p/s), 10 % fetal bovine serum (FBS) in Dulbecco's Modified Eagle's medium 
(DMEM) /F-12 1:1 mixture with GlutaMAX supplement. The beads and the cell medium were 
shaked in the well plate by hand until the beads were uniform on the surface and a single lay-
er of silica beads were formed under microscope. After that, the cells (8 х 104 cells per well) 
were injected into each well and air bubbles were avoided during the injection.  The cell den-
sity was chosen at 8 х 104 cells per well, so that we can better mimic the cell density in the 
cortex from mouse at around 91,000 cells/mm3, while we can reach the density at approxi-
mately 75,000 cells/ mm3 in our beads culture environment [1, 125]. After 4 h, the cells were 
attached on the beads surface under microscope. The DMEM/F-12 GlutaMAX and the p/s so-
lutions were ordered from Invitrogen (Carlsbad, CA) and the PLL and FBS were ordered from 
Sigma-Aldrich.  
As seen from Figure 51 A, the cells were growing on the silica beads by the top focus 
plane with the microscope, and also the beads surfaces were covered with cells relatively uni-
formly (Figure 51 B and C). This gave us the evidence that the cells can be cultured on the 
coated silica beads and protocol of manipulating cells on the coated beads can be applied for 
primary cortical culture. 
4.3.2 Primary neural cell culture on silica beads and patterned in micro-
fluidic device 
For the primary neural cell culture, the dissection process was followed with the method 
present in Section 2.2.3. The protocol of culturing the primary cortical neurons onto the silica 
beads culture was as same as for the SHSY-5Y cell line present in Section 4.3.1. Under the mi-
croscope, we see the cells were on the surface between the beads and move the well plate into 
incubator. After 4 hours, we see the cells have already started to grow on the beads surface 
and keep the well plate in the incubator until the next day to transfer the beads into microflu-
idic device 
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Figure 51: Images of the silica beads with neural culture on the surface, from the top surface focus plane to-
wards the bottom direction. Images were taken by phase contrast microscope. Scale: 50 μm 
 
Figure 52: Neurons growing on the surface of silica beads inside the layer-pattern microfluidic device.  (B) 
Neurites are growing in the channel without silica beads. (C) Neurons growing on the silica beads are indicat-
ed by yellow arrows. Scale in Fig. A is 100 μm. Images were taken by phase contrast microscope 
A B 
C 
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First, we tried to inject the beads with cells into the two lateral channels while the two 
middle channels were empty, so that the neurite from the cells could grow through the middle 
channels and we were be able to observe the neural network under the microscope without 
staining the cells. Neurites were observed in the middle channels without beads. These neu-
rites were from the neurons growing on the two lateral layers of beads (Figure 52).  The neu-
rites were growing relatively equally distributed and the neurons were observed on the silica 
beads. This result proves that the primary cortical neurons were successfully cultured on the 
PLL-coated silica beads and the neurites were able to grow through the neighboured bead and 
grow longer and longer. In this way, one cell population could extend to other area in the 
channels and communicate with other neuronal population. 
After the trial of observing the neural growth in a 4-layer pattern microfluidic device 
while leaving two middle channels empty, we injected beads with cells into all the 4 layers in 
the microfluidic device. The neural network was built after 21 DIV (Figure 53) and was 
stained with MAP2 to show the neurites growing between the beads layers. An image of a cul-
ture on DIV 6 was taken to analyze the cell distribution and cell density. The distribution of 
the neurons growing inside the beads in the microfluidic device was analyzed based the 3D 
image we obtained from confocal microscope. The beads were loaded into a single layer inside 
the microfluidic device. It is observed that the neurons were uniformly distributed in the lay-
er-pattern microfluidic device (Figure 53 A). The position of the cells in vertical direction was 
analyzed as well to evaluate the cell sedimentation by gravity in the channel, which could be a 
problem for 3D gel culture because of the slow gel solidification. As we observed from Figure 
54, the neurons were equally distributed in the vertical direction within the imaged specimen. 
In the end, the cell density for this beads culture was calculated based on the 3D image. There 
are around 4.6 cells per bead on average which is consist with the previous study [125], and 
the cell density in this cell culture was around 55 million cells/ml. This result proved that this 
method of culturing neural cells on silica beads to build a 3D neural network was feasible and 
the next step was to use the beads with different coating for different guidance and observe 
the cell-cell interactions between different cell populations. 
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                                                       A                                                                                                      B 
Figure 53: A microfluidic device with 4 layers pattern and fully filled with silica beads (Fig. A) and a 3D neural 
cell culture on silica beads captured from a 3D imaging result of one channel (Staining: MAP2, neurite) (Fig. B).  
Scales are 100 μm and 50 μm in Fig. 5-6 A and B respectively. . Images A was taken by phase contrast micro-
scope and image B was taken by confocal microscope 
 
                                                                   A                                                                                              B 
Figure 54: Cell density analysis and cell position in gel analysis based on a 3D image of the beads with cells in a 
microfluidic device (DIV 6) (one layer of beads).  Cell density analysis and cell position in gel analysis based on 
a 3D image of the beads with cells in a microfluidic device (DIV 12). (A) Analysis for the cell density. (B) Analy-
sis for cell settlement 
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4.3.3 cAMP and cGMP guidance experiment using 3D silica beads culture 
 4.3.3.1 Experiment design 
Benefiting from the assembly properties of the silica beads with neurons, we pattern the 
beads carrying neurons in different layers in microfluidic device. By patterning beads with 
cells on the surface and the coated the beads with chemical attractant as guiding cues for the 
neurons, we try to build selectively interacted neuronal network that can be useful to answer 
specific questions from neuroscience. More specifically in our experiment, the design of the 4 
layer-patterned arrangement of the beads layers is show in Figure 55. There were 4 layers of 
beads, A, B, C and D. The 45 μm silica beads were either with PLL coating for cell adhesion or 
PLL coating and also the guidance coating solution like cGMP and cAMP). The lentivirus trans-
fected neurons are loaded into layer A (tdTomato expression in red) and D (GFP expression in 
green). The environmental cues for the guidance of the neurons are in layer B (cGMP coated 
beads to attract dendrites) and C (cAMP coated beads to attract axon). Based on this cell cul-
ture model, we intend to observe the structure of the layer-pattern neural network and also 
investigate the effects on the cell populations under different environmental guidance cues 
and the interactions between different cell populations. Furthermore, as a fundamental prop-
erty in neurons, neural activity is also studied by applying fluorescent calcium indicator imag-
ing. 
 
 
 4.3.3.2 Beads coating and neuronal culture maintenance 
The beads sterilization protocol and PLL coating protocol for the neuronal culture were 
as same as presented in Section 4.3.1. For the guidance beads coatings for cAMP and cGMP 
guidance, 20 mM of cAMP and cGMP were used for the beads coating, and the washing steps 
for the coating were as same as presented in Section 4.3.1. The lentivirus infections for the 
GFP and tdTomato neurons were from Dr. Sophie Pautot’s lab in Dresden.  
 
Figure 55: The experiment design of the arrangement of the beads layers 
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 4.3.3.3 Beads loading manipulation in microfluidic device 
For our beads loading, we first took the 24 well plate out of the incubator and kept in at 
45° to let the beads to deposit and accumulated to one corner. Then we used a 200 μl gel load-
ing tip which has an extremely long thin tip at the end to suck the beads out from the well-
plate and injected them slowly into the microfluidic device. 
 
 
 
 
 
Figure 56: Systematic diagram of loading different layers of beads into microfluidic device 
  
Figure 57: Cell culture on silica beads in microfluidic device on day 6, 9 and 12.  Staining: GFP neuron, green; 
tdTomato neuron: red. Images were taken by confocal microscope. Scale: 100 μm 
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The sequence of loading beads into different layers is very strongly linked to the cell cul-
ture quality since the vibration inside the device will potentially damage the cells. The proce-
dure we used for beads loading is show in Figure 56. First, the device was filled with medium 
to avoid air bubbles for further beads loading. Then the guidance layers B and C were loaded 
with beads without cells but with different guidance coatings. In the end, the layer D and layer 
A were loaded with beads with virus transfected neurons. This neural culture was kept in in-
cubator for 12 days and the neural network development was presented in Figure 57. Com-
pared to the GFP neurons, the tdTomato neurons were relatively weak and this was probably 
due to the infection step. 
 
 4.3.3.4 cAMP and cGMP guidance effect 
From the guidance result we obtained in Figure 58 A, the cell bodies stayed at their orig-
inal beads layer, and only a few cells either migrated to other beads layers or transported by 
the shaking during the beads loading. The neurite included the dendrite and axon were 
stained with Tuj-1 in green (Figure 58 C), and the axon was stained with SMI312 (Figure 58 
D). From the merged image (Figure 58 E), we observed most of the neurite in the guiding lay-
er is axon because of the lack of green color observed in the merged image and mostly den-
drite was located at the cell culture layer. The guidance effects from the cAMP and cGMP coat-
ed beads were not well observed probably due to the short function period of the coated 
beads (the first 2 days have the best selection function [125]). Unfortunately, the left lateral 
cell layer with lentivirus infected neurons with tdTomato expression (red color) was not 
clearly observed from Figure 58. No result was obtained from the tdTomato neuronal popula-
tion for the guidance experiment.  
In this first part of this chapter, we focused on 3D neural cell culture on silica beads and 
we transferred the silica beads with neurons into a microfluidic device with layer pattern. The 
neurons were successfully cultured on the silica beads, and they built layer pattern neural 
network on the silica beads. These results proved the possibility of culturing neurons on silica 
beads and using silica bead as a carrier for the neurons in order to build layer pattern to mim-
ic the neuron-to-neuron interaction model for neuroscience studies. This method is more 
convenient than in the normal microfluidic chips that build the different layers by running 
laminar flow. It does not require temperature control as well which could be a problem for the 
manipulation with 3D gel scaffold. This 3D silica beads culture technology is promising for 
neural cell culture patterning in a 3D environment. 
4.4 3D agarose-alginate beads culture in microfluidic device 
4.4.1 Agarose-alginate beads  
Recent studies highlight the shortcomings of commercial glass particles and stress the 
benefit of using soft microgel particles (MGPs) instead [127]. We started to investigate on the 
Inspired from the 3D silica beads neuronal culture concept for patterning neuronal network 
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illustrated above and the Hanging Drop Array technique described in Section 1.4.3, agarose-
alginate gel was chosen to build a 3D gel based neuronal culture in microfluidic device with 
layer pattern. Agarose is a widely used naturally derived hydrogel with neutral polymer 
chains. It has good mechanical properties, large pore size for diffusion and growth, and specif-
ic thermosetting behaviour and hysteresis. Agarose is chosen as the scaffold backbone is be-
cause it lacks of cell surface receptor binding domains and the established procedures for the 
controlled coupling of bioactive ligands [29] which are essential properties to open new per-
spectives for neural tissue engineering applications which may lead to drug development. The 
concentration of the agarose for fabricating 3D beads was at 0.5 % (w/v) which has the stiff-
ness between 2 kPa and 5 kPa. Alginate, one of the most used hydrogels for cell encapsulation 
today, was used as free alginate chains at the concentration of 0.3 % (w/v) to improve the 
neural attachment and survival rate. B27 was added as well to reach a final concentration at 2 
% to improve the cell culture growth. 
4.4.2 Agarose-alginate beads fabrication 
For the fabrication of agarose-alginate gel beads, we applied a gel vortexing method to 
use the shear force from vortex to separate the gel into small sizes beads [14]. For more pre-
cisely control for the fabrication of beads, droplets microfluidic device can be used as well. In 
this experiment, the size of the beads is not critical, that is the reason that vortex approach is 
achieved instead of applying droplets microfluidic device. Agarose type VII at 1 % w/v (e.g., 
 
 
 
Figure 58: Layer pattern 3D silica beads culture I microfluidic device on 12 DIV.  (B) Nucleus, DAPI, blue. (C) 
Neurite, Tuj-1, green. (D) Axon, SMI312, pink. (E) Merged by staining of Fig. B, C and D.  Scale in Fig. A is 100 
μm, Scales in Fig. B, C, D and E are 50 μm. Images were taken by confocal microscope 
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0.05 g in 5 ml PBS) and alginate at 0.6 % w/v (e.g., 0.03 g in 5 ml) were the main components 
for the scaffold. The powder of agarose and alginate were weighed and transferred into a 50 
ml falcon tube under the cell culture hood. Then the 0.05 g agarose and 0.03 g alginate were 
mixed with 5 ml deionized (DI) water, heated up in the microwave to dissolve the mixture. 
When the gel cooled down, 620 μl of gel mixture was mixed with 580 μl of cell culture medi-
um, 30 μl of pluronic acid and 13 μl of B27, and then mixed by vortex machine for approxi-
mately 1 min Pluronic F-68 helps to protect fragile cell membranes from disruption during 
agitation of suspension cultures. In the end, the agarose-alginate mixture reached at the final 
concentration at 0.5 % w/v agarose, 0.3 % w/v alginate and 1 % B27, and mixed with 107 
cells in neurobasal medium. For the beads fabrication, we injected the gel and cell mixture 
drop by drop and slowly into 15 ml silicon oil (Dimethylpolysiloxane, viscosity at 50 cen-
tistokes) carried by 50 ml falcon tube, under continuously mixing by vortex machine. During 
the vortexing, the gel was separated into much smaller spherical shape beads and became 
froze when the falcon tube was transferred on the crushed ice container for 10 min. Then the 
mixture of silicon oil with frozen beads was centrifuged at 2000 rpm for 5 min. After the cen-
trifugation, an interface appeared between the oil and water phases. Then the silicon oil was 
carefully removed and the water phase solution with frozen beads inside was transferred into 
another 15 ml falcon tube. To further wash away the silicon oil, we added 10 ml of PBS into 
the 15 ml falcon tube with frozen beads and centrifuge the mixture at 2000 rpm for 5 min. The 
remaining oil was carefully pipetted out after the centrifuge. In the end, we passed the gel 
beads in the cell culture medium through the filters of 40 μm and 70 μm and collected the 
beads between 40 μm and 70 μm (Figure 59). The beads were kept cell culture medium and 
maintained in the incubator waiting for the loading process to transfer beads into the micro-
fluidic device. 
 
 
 
 
4.4.3 3D agarose-alginate beads culture in layered-pattern in microfluidic 
device 
 
                                    A                                                                     B                                                                     C 
Figure 59:  Collected gel-beads without cells inside.  (A) Beads under 40 μm in diameter. (B) Beads between 40 
μm to 70 μm in diameter. (C) Beads bigger than 70 μm in diameter. Scale: 50 μm 
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The agarose-alginate beads with neurons inside were loaded into the layer-pattern microflu-
idic device. It was observed that he primary neurons were growing inside the beads and some 
of their neurites were growing out of beads and trying to bridge to another beads (Figure 60). 
The distribution of the neurons growing inside the beads in the microfluidic device was ana-
lyzed based on the 3D image we obtained from confocal microscope. The beads were loaded 
into a single layer inside the microfluidic device. It is observed that the neurons were relative-
ly uniformly distributed in the layer pattern microfluidic device (Figure 61 A). The position of 
the cells in vertical direction was analyzed as well to evaluate the distribution of the cells in 
the device horizontally and vertically because the cell sedimentation caused by gravity in the 
gel could be a problem for 3D gel culture because of the slow gel solidification. As we ob-
served from Figure 61 B, the neurons were equally distributed in the vertical direction within 
the imaged specimen. In the end, the cell density for this beads culture was calculated based 
on the 3D image. There were around 4.19 cells per bead on average, and the cell density in 
this cell culture was around 50 million cells/ml , which is a high density as a 3D cell culture 
and it is 50 times more than a standard 2D cell culture [83].  
Compared to the silica beads, the biggest advantage of agarose-alginate beads is the neu-
rons grow inside the agarose-alginate beads, while for silica beads neurons grow on the sur-
face. This is an important factor for loading beads into the microfluidic device because the 
collision between the beads during the flowing procedure may damage the neurons on the 
surface. For the agarose-alginate beads, they behave like cushioning for the neurons that can 
maximum protect the neurons. That is another reason that the agarose-alginate beads with 
cells should be loaded into the microfluidic device immediately after the fabrication of the 
beads, before the development of the neurons start. However, for the silica beads, we have to 
wait for the neurons to attach well on the silica surface to avoid neurons fall from the carrying 
beads during the loading, but the developing neurons can have severe damage during the 
beads loading. Another advantage of the agarose-alginate beads is they have soft tissue which 
more closer to the tissue from native brain. They have high elasticity, which means higher 
deformability, and this allows the gel scaffold to easily adapt to the neurons deformation dur-
ing neural development. From the quantity result, as a cell carrier, the silica beads and the 
agarose-alginate beads reached similar amount of cells per bead and similar density for cell 
culture. Further investigation is necessary to perform in the future, e.g., the cell viability as-
says, increase the density of cells in the gel and try long duration agarose-alginate neuronal 
culture, in order to move forward on applying this method for neuroscience research. 
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Figure 60: Agarose-alginate beads with cells inside were patterned into two layers inside a microfluidic device 
that has pillars for layer pattern (DIV 12).  (B) Detail of neuron cells growing inside the beads. The red arrow 
indicated that a neuron was trying to bridge between two beads by its neurites. Scale in Fig. A: 100 μm. Scale 
in Fig. B: 50 μm 
 
Figure 61:  Cell density analysis and cell position in gel analysis based on a 3D image of the beads with cells in 
a microfluidic device (DIV 12) (one layer of beads).  (A) Analysis for the cell density. (B) Analysis for cell 
settlement 
 
A B 
A B 
4. 3D beads-based neuronal culture in microfluidic device 
88 
4.5 Conclusion 
In this chapter, we explore the 3D neuronal culture on two different types of beads, silica 
beads and agarose-alginate beads, and the neurons were successfully cultured on both beads 
environments. Benefitting from the microfluidic device with layer pattern, we transferred the 
two types of beads with neurons into the microfluidic device. Neural network was built be-
tween different layers of silica beads. It proved the possibility of culturing neurons on silica 
beads and using silica bead as a carrier for the neurons in order to build layer pattern models 
for brain studies. The agarose-alginate beads have more advantages concerning the proper-
ties of the material itself. It reached similar cell density of 3D neuronal culture as the silica 
beads. Both two methods for culturing neurons in/on beads are adaptable for microfluidic 
device with layer pattern. They are promising techniques for neural cell culture patterning in 
a 3D environment to mimic the neuron-to-neuron interaction model in microfluidic device 
and study AD in a 3D environment. These patternable beads-based methods fit with the MEA 
device as well to build up 3D cell culture for recording. However, the challenge is to obtain 
high quality signal from the MEA recording device as the distance between neurons and elec-
trodes are increased in 3D cell culture comparing to 2D cell culture.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“I have discovered the secret that after climbing a great hill, one only finds 
that there are many more hills to climb.” 
by Nelson Mandela 
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5.1 Conclusions   
5.1.1 PDMS and SU-8 bonding method for microfluidic-MEA device inte-
gration 
The compartmentalized microfluidic device and the MEA device with 60 recording elec-
trodes are fabricated in this thesis. These two devices are also integrated to build a microflu-
idic-MEA device. However, a bonding method was required to bond the microfluidic device 
made of PDMS and the MEA device with a SU-8 insulation layer on its top. It was an issue to 
bond the PDMS and SU-8 materials because of the chemical bonds on each surface. After theo-
ry studies, a surface silanization method using APTES molecule was found and a series of tests 
had been undertaken to investigate different bonding methods, including the XPS surface 
analysis and tensile strength tests. In the end, we found that there was strong evidence com-
ing from the XPS analysis of APTES molecule presence on the PDMS surface after the liquid-
phase silanization method instead of the vapor-phase silanization methods. Meanwhile, the 
SU-8 material without hard bake step during fabrication provided better performance on the 
bonding quality during the tensile strength tests. Based on this APTES silanization method, we 
were able to perform the integration and therefore build our microfluidic-MEA device. 
5.1.2 Applications of using microfluidic and microfluidic-MEA devices for 
AD propagation studies 
These neuronal morphological results from the compartmentalized microfluidic device 
confirmed the feasibility of using microfluidic devices in neural cell culture for morphological 
studies. The axonal network isolation design proved its advantages for neurodegenerative 
disease research. Furthermore, the integrated microfluidic-MEA device that has a co-
pathological neuronal culture model was built to mimic the AD spreading model by neuron-
to-neuron connections and to investigate the electrophysiological alternations during disease 
propagation. The morphological result from the microfluidic device proves our hypotheses on 
the neuron-to-neuron transmission. Tau pathology propagated between the two distinct neu-
ronal populations through the isolated axonal connections and this confirmed our hypothesis 
about the axonal transportation plays an important role during disease progression. The pat-
tern of hp-Tau's first appearance in the axonal network confirmed the hypothesis proposed in 
previous publications.  
Based on the result from the MEA device recording, the electrophysiological alteration 
was observed. Depends on the results from the low and high concentrations of drug exposure, 
the two neural activity patterns were observed: depression and temporary-revive electro-
physiological patterns during AD propagation. This confirmed our hypothesis on the concen-
tration-dependent effect of drug during AD propagation. After the comparison with the mor-
phological and electrophysiological result, an innovative result was found that the functional 
changes occur prior to the structural changes as well. This microfluidic-MEA device is able to 
give us more knowledge about AD propagation in vitro, which indicates that this device will 
have a promising future in neurodegenerative disease studies and pharmaceutical studies for 
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drug effect tests, while potentially helping to diagnose AD early. The drug effects on the activi-
ty of the neuronal network and the sequential occurrence between the morphological and 
electrophysiological alterations both demonstrate that this microfluidic-MEA device fulfilled 
the functions that we originally wanted and required to obtain from this device. 
5.1.3 Building a layer-pattern neuronal culture model in a microfluidic 
device 
In this thesis, two microfluidic devices with different designs were fabricated, including 
a 3-compartment device and a layer-pattern device. The 3-compartment microfluidic device, 
which provides compartmentalized neuronal culture, is used for morphological observation 
and integrated with the MEA recording device to build microfluidic-MEA device. With the lay-
er-pattern microfluidic device, we explored 3D neuronal culture on silica and agarose-alginate 
gel beads cultures in a layer-pattern microfluidic device, in order to mimic the cortex struc-
ture, which contains layers of cells in native brain tissues. Inspired from Sophie Pautot’s pre-
vious work [125] on culturing neurons on silica beads and building a 3D neuronal culture 
network in the vertical direction, we intended to bring silica beads with neuronal culture on 
their surfaces into a microfluidic device with layer-pattern. The neural cell culture was suc-
cessfully brought onto the silica beads and neurites were observed around the silica beads' 
surfaces. By leaving the middle layers empty, the neurites grew out from the silica beads and 
extended into the empty layers. This preliminary result proves the success of culturing neu-
rons on silica beads and this beads-based culture technique and further experiments were 
done on building a neuronal network with guidance.  With cGMP and cAMP coating on the 
silica beads, we expected to observe a selective guidance pattern from the layer-pattern silica 
beads culture. Unfortunately, the guiding function was not clearly observed in the neuronal 
network based on the observation with confocal imaging. This is probably due to the short 
functional period of the molecule coating.  
Besides the silica beads, we explored the culture of the neurons in agarose-alginate 
beads. The beads were fabricated without using microfabrication technologies. Through a 
strong but enough vortex process, the gel was separated into spheroids and could be distin-
guished and extracted from the oil environment for collection. The neurons were encapsulat-
ed into the agarose and agarose gel mixture, while being distributed uniformly inside the 
beads when the gel was vortexed. Compared to the laminar flow of gel to build layer pattern 
in a microfluidic device, this method gives us the convenience of patterning different types of 
cells into layers without gel mixing and avoiding diffusion during transportation and it can 
further prevent the settlement of cells by gravity during the long gel freezing period.  
Some preliminary results about 3D neuronal culture models with the silica and agarose-
alginate beads were obtained in our layer pattern microfluidic device. Based on all these 
structural characteristics, we think our microfluidic device with layer-pattern has its 
strengths in building an artificial neural cell layer mimicking typical cortical cell layers pat-
terns and for neuron-to-neuron studies in 3D neuronal culture as well. Further experiments 
can be undertaken to increase cell survival in the gel culture as well as to find better solution 
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to flow the beads into the patterned channel inside the microfluidic devices. Because of the 
large dimensions of the culture niche and the gel mixture, good staining quality and imaging 
methods are required in the future for obtaining better observations on the neuronal culture 
network. 
 
5.2 Perspectives 
5.2.1 Axonal transmission mechanisms 
Based on the morphological results from the microfluidic device, we observed the hp-
Tau first accumulated in the axon region and then appeared in the OA-exposed and OA-
unexposed cell populations. For the two neuronal populations, axons provide the possibilities 
to communicate with each other. There are two ways that can explain how the hp-Tau propa-
gates, either by direct physical contact between the axons from the two cell populations for 
information exchange or the hp-Tau is released into the culture medium by the axons from 
the diseased cell population. It is possible that at the late stage of AD propagation, the dis-
eased neuronal cell population released hp-Tau into its surrounding environment and it dif-
fuses through the long junction channels to the other regions and has an effect on the unex-
posed cell population. To understand the mechanisms at the axonal network during disease 
propagation, microfluidic device with more controls are required to distinguish the functions 
of the axonal network and other markers can be used to distinguish the synaptic function. For 
the future experiment, instead of using OA to induce the neurons to build the diseased model 
which could possibly involve other pathologies, it will bring great value to use different forms 
of Tau and Aβ to induce the cells directly such as synthetic Tau or Aβ aggregates to exclude 
other possibilities during disease transmission. Further experiment can investigate more in 
detail during disease progression, such as focusing on synapse level to study synaptic trans-
mission in spreading. 
5.2.2 Relation between Tau and Aβ 
As Ittner LM and Gotz J proposed in 2011, it is possible that Tau protein and Aβ have 
some interactions in AD[68]. They provided three possible models of this interaction. First, Aβ 
drives Tau pathology by causing hyperphosphorylation of Tau protein, which in turn mediates 
toxicity in neurons (Figure 62 A). Secondly, Tau mediates Aβ toxicity and hence, Aβ toxicity is 
critically dependent on the presence of Tau for example, in the dendrite (Figure 62 B). The 
last case is that Aβ and Tau target cellular processes or organelles synergistically, thereby 
possibly amplifying the toxic effects from each other (Figure 62 C). This is one of the works in 
the literature that have disclosed the possible relations between Tau and Aβ during AD prop-
agation [24]. Some other cells in the brain could also participate during AD propagation, for 
example, the glia cells such as astrocytes and microglia. Glia cells may perceive Aβ oligomers 
and fibrils as foreign bodies and could as a result play a role in the pathogenesis of AD [140]. 
The application of microfluidics to the study of the interaction between Tau protein, amyloid 
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β and other possible cell types shows great promise in better understanding AD, and may po-
tentially help in fulfilling the urgent need of finding a cure for AD. 
 
 
 
 
5.2.3 3D cell culture model for AD studies 
Most of the culture models used for AD studies are still focusing on in vitro 2D culture 
and in vivo experiments. The in vivo models provides the complexity of the brain function, 
however, it is difficult to distinguish the different functions and relations between each com-
ponent in a native brain. From this point of view, the in vitro culture models provide some 
advantages. Compared to 2D neuronal culture, the 3D models can better present the key 
events of AD pathology, especially for observations on NFTs and Aβ plaques. For example, 
secreted Aβ first diffuses into the external environment, then Aβ deposits accumulate, finally 
forming Aβ plaques [24]. It is difficult to mimic this situation in a 2D neural cell culture envi-
ronment, because the secreted Aβ diffuses into a large volume of culture medium and may 
even be washed away when the culture medium is refilled with fresh medium, which is neces-
sary for neuronal culture. Although the 3D neuronal culture provides promising results on 
mimicking the brain, some challenges still exist. AD is a long term neurodegenerative disease 
and the degeneration of the brain takes years to develop. However, for in vitro cell culture, 
normally it takes around a month between building a mature neuronal network to observing 
the disease propagation and finally causing neuronal death in the end. As a result  the recon-
stitution of AD conditions and the observation of the late stages of neurodegeneration in vitro 
becomes a problem [30]. Another issue that 3D culture brings is the low imaging quality aris-
ing from the increased thickness of the 3D tissue. Therefore, researchers are in great need of 
new microscopy technologies that can solve these problems. 
 
                  A                                                     B                                                                                   C 
Figure 62: Three possible models of interesting interaction between Aβ and Tau.  Reprinted from[68] with 
permission 
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5.2.4 Towards building a brain-on-a-chip 
With the development of microtechnology, numbers of researchers are focusing on 
building artificial organs mimicking a native organ (usually called “organ-on-a-chip”), such as 
the “liver-on-a-chip” which is created by mimic the liver sinusoid and acinus structure to ac-
celerate drug testing and toxicology studies[91]. The brain, regarded as the most complex or-
gan in the body by the vast majority of scientists, is also being built in vitro to create brain-like 
tissue which can mimic the structural and functional features of the native brain. For example, 
we tried to use a layer-patterned microfluidic device to mimic the layer structure of the cor-
tex. In previous work, people use microfluidic devices to provide a constant flow of fluid in 
order to mimic the brain's interstitial fluid, which provides functions such as providing nutri-
ents, oxygen, cytokine transport and waste removal in native tissue [120]. Towards building a 
brain-on-a-chip, we selectively mimic some typical characteristics of the brain and focus on 
some specific issues where microdevices can provide similar structures and/or functions. Mi-
crodevices have great potential for building in vitro brain models for disease mechanism stud-
ies and drug effect tests. 
5.2.5 Benefits from using miniaturized devices 
Overall, there are many benefits for using miniaturized device for in vitro experiments. 
They provide better control over experiments in order to achieve more stable and accurate 
results at the microscale. Furthermore, the miniaturized devices, with their micron-sized 
channels, require much less cell quantities than normal culture dishes, such as petri dishes 
and well-plates, which means less animals like mice or rats need to be sacrificed for one ex-
periment. At the same time, the biological experiment cost can be reduced significantly, be-
cause of the lower quantities of proteins, antibodies and other expensive solutions necessary 
for experimentation. The devices can also be designed to be reusable. For instance, our micro-
fluidic-MEA device can be used around 20 times before disposal, under proper maintenance. 
Finally, the compartmentalized microfluidic device and the microfluidic-MEA devices we de-
veloped in this thesis are very promising tools for neurodegenerative disease studies and can 
potentially be used for pharmaceutical tests for drug development. 
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